TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-379724	tRNA Aminoacylation	2.02803520229366e-06	-13.108443114253	42	11	0.0291005291005291	378	8202	833,79731,2617,3035,10667,23438,4141,8565,16,6897,7453	CARS,NARS2,GARS,HARS,FARS2,HARS2,MARS,YARS,AARS,TARS,WARS
R-HSA-379716	Cytosolic tRNA aminoacylation	7.25308031879294e-06	-11.8340843077724	24	8	0.0211640211640212	378	8202	833,2617,3035,4141,8565,16,6897,7453	CARS,GARS,HARS,MARS,YARS,AARS,TARS,WARS
R-HSA-73847	Purine metabolism	9.50237574611486e-05	-9.26138361908975	33	8	0.0211640211640212	378	8202	3251,2618,471,353,30833,3615,132,4907	HPRT1,GART,ATIC,APRT,NT5C,IMPDH2,ADK,NT5E
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.00029305020233174	-8.13516662460788	212	22	0.0582010582010582	378	8202	3992,80205,5468,27242,133522,56895,84803,23389,253558,51129,788,123,57761,6721,51,51586,9663,26027,4199,6907,79888,6576	FADS1,CHD9,PPARG,TNFRSF21,PPARGC1B,AGPAT4,GPAT3,MED13L,LCLAT1,ANGPTL4,SLC25A20,PLIN2,TRIB3,SREBF2,ACOX1,MED15,LPIN2,ACOT11,ME1,TBL1X,LPCAT1,SLC25A1
R-HSA-1989781	PPARA activates gene expression	0.000597830963999217	-7.42220251286966	112	14	0.037037037037037	378	8202	123,3992,57761,80205,6721,5468,27242,133522,51,51586,23389,4199,6907,51129	PLIN2,FADS1,TRIB3,CHD9,SREBF2,PPARG,TNFRSF21,PPARGC1B,ACOX1,MED15,MED13L,ME1,TBL1X,ANGPTL4
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.000781412539011493	-7.15440732861834	115	14	0.037037037037037	378	8202	123,3992,57761,80205,6721,5468,27242,133522,51,51586,23389,4199,6907,51129	PLIN2,FADS1,TRIB3,CHD9,SREBF2,PPARG,TNFRSF21,PPARGC1B,ACOX1,MED15,MED13L,ME1,TBL1X,ANGPTL4
R-HSA-418457	cGMP effects	0.00105411714492972	-6.85505169184183	18	5	0.0132275132275132	378	8202	5138,5140,10846,5152,5139	PDE2A,PDE3B,PDE10A,PDE9A,PDE3A
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.00223339526773361	-6.10423230981683	21	5	0.0132275132275132	378	8202	2254,4893,6464,2247,2260	FGF9,NRAS,SHC1,FGF2,FGFR1
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.00305777570288476	-5.79006752181584	54	8	0.0211640211640212	378	8202	80205,3422,6721,3638,9871,6713,6907,1717	CHD9,IDI1,SREBF2,INSIG1,SEC24D,SQLE,TBL1X,DHCR7
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.0034232334999567	-5.67716970675721	23	5	0.0132275132275132	378	8202	2744,440,5832,29968,5831	GLS,ASNS,ALDH18A1,PSAT1,PYCR1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.00416337514203563	-5.48142920144093	24	5	0.0132275132275132	378	8202	5138,5140,10846,5152,5139	PDE2A,PDE3B,PDE10A,PDE9A,PDE3A
R-HSA-15869	Metabolism of nucleotides	0.00423471158321346	-5.46444005633456	82	10	0.0264550264550265	378	8202	3251,2618,204,7378,471,353,30833,3615,132,4907	HPRT1,GART,AK2,UPP1,ATIC,APRT,NT5C,IMPDH2,ADK,NT5E
R-HSA-556833	Metabolism of lipids and lipoproteins	0.00530844257388433	-5.23845678733607	628	43	0.113756613756614	378	8202	1591,2678,9871,27242,133522,84803,23389,81579,10162,79642,8867,253558,5305,788,3422,6721,9663,26027,4199,8871,79888,11343,5567,6576,3992,80205,5468,56895,56261,6916,10087,23760,51129,123,57761,3638,51,51586,6713,8714,1800,6907,1717	CYP24A1,GGT1,SEC24D,TNFRSF21,PPARGC1B,GPAT3,MED13L,PLA2G12A,LPCAT3,ARSJ,SYNJ1,LCLAT1,PIP4K2A,SLC25A20,IDI1,SREBF2,LPIN2,ACOT11,ME1,SYNJ2,LPCAT1,MGLL,PRKACB,SLC25A1,FADS1,CHD9,PPARG,AGPAT4,GPCPD1,TBXAS1,COL4A3BP,PITPNB,ANGPTL4,PLIN2,TRIB3,INSIG1,ACOX1,MED15,SQLE,ABCC3,DPEP1,TBL1X,DHCR7
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.0059741232861443	-5.12031792228293	26	5	0.0132275132275132	378	8202	4088,56937,7048,51377,4092	SMAD3,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.0061614749027573	-5.08943909783024	3	2	0.00529100529100529	378	8202	10644,10643	IGF2BP2,IGF2BP3
R-HSA-2142845	Hyaluronan metabolism	0.00655117354059085	-5.02811107888096	17	4	0.0105820105820106	378	8202	3373,960,3038,57214	HYAL1,CD44,HAS3,CEMIP
R-HSA-189445	Metabolism of porphyrins	0.00655117354059085	-5.02811107888096	17	4	0.0105820105820106	378	8202	210,3163,1352,7389	ALAD,HMOX2,COX10,UROD
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.0066440273263469	-5.01403697430353	74	9	0.0238095238095238	378	8202	1912,8924,197370,286053,22955,672,23279,648,7518	PHC2,HERC2,NSMCE1,NSMCE2,SCMH1,BRCA1,NUP160,BMI1,XRCC4
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.0066440273263469	-5.01403697430353	74	9	0.0238095238095238	378	8202	1912,8924,197370,286053,22955,672,23279,648,7518	PHC2,HERC2,NSMCE1,NSMCE2,SCMH1,BRCA1,NUP160,BMI1,XRCC4
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.00812176108223946	-4.81320826627487	18	4	0.0105820105820106	378	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-1483166	Synthesis of PA	0.00827739416999675	-4.79422707388625	28	5	0.0132275132275132	378	8202	81579,79888,253558,56895,84803	PLA2G12A,LPCAT1,LCLAT1,AGPAT4,GPAT3
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.00933518543193712	-4.67396463802536	78	9	0.0238095238095238	378	8202	80205,6721,5468,1019,51586,23389,6907,7026,51129	CHD9,SREBF2,PPARG,CDK4,MED15,MED13L,TBL1X,NR2F2,ANGPTL4
R-HSA-2990846	SUMOylation	0.010121153217194	-4.59312766734693	79	9	0.0238095238095238	378	8202	1912,8924,197370,286053,22955,672,23279,648,7518	PHC2,HERC2,NSMCE1,NSMCE2,SCMH1,BRCA1,NUP160,BMI1,XRCC4
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.0105472687451525	-4.55188833929242	41	6	0.0158730158730159	378	8202	6713,80205,6907,3422,6721,1717	SQLE,CHD9,TBL1X,IDI1,SREBF2,DHCR7
R-HSA-167172	Transcription of the HIV genome	0.011421364013178	-4.47226964115313	67	8	0.0211640211640212	378	8202	2967,6827,6872,83860,8731,6924,2965,51616	GTF2H3,SUPT4H1,TAF1,TAF3,RNMT,TCEB3,GTF2H1,TAF9B
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0118408605277968	-4.43619897245476	42	6	0.0158730158730159	378	8202	3910,3691,5578,2247,3911,3673	LAMA4,ITGB4,PRKCA,FGF2,LAMA5,ITGA2
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.0119476991535904	-4.42721655859122	4	2	0.00529100529100529	378	8202	10973,51008	ASCC3,ASCC1
R-HSA-3000170	Syndecan interactions	0.0119585300986092	-4.42631043946673	20	4	0.0105820105820106	378	8202	3691,5578,2247,3673	ITGB4,PRKCA,FGF2,ITGA2
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.0121514906246139	-4.41030343156738	11	3	0.00793650793650794	378	8202	3615,2618,471	IMPDH2,GART,ATIC
R-HSA-189451	Heme biosynthesis	0.0121514906246139	-4.41030343156738	11	3	0.00793650793650794	378	8202	210,1352,7389	ALAD,COX10,UROD
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.0121514906246139	-4.41030343156738	11	3	0.00793650793650794	378	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-162587	HIV Life Cycle	0.0123078906258759	-4.39751470798725	140	13	0.0343915343915344	378	8202	2967,3836,6827,6872,83860,8731,79720,6924,2965,7518,23279,51616,92421	GTF2H3,KPNA1,SUPT4H1,TAF1,TAF3,RNMT,VPS37B,TCEB3,GTF2H1,XRCC4,NUP160,TAF9B,CHMP4C
R-HSA-1430728	Metabolism	0.0124434352207698	-4.38656208664291	1691	96	0.253968253968254	378	8202	6723,1591,2678,27242,133522,57214,113278,7389,10162,79642,5578,3163,1352,8867,23279,253558,80308,3422,440,6721,9663,3373,4199,30833,11343,2787,5567,80205,5468,7378,56261,10087,23760,4953,4257,2770,5831,123,54331,2744,3251,3638,3141,210,8714,9942,115677,204,6819,9871,84803,5646,23389,8604,81579,353,5305,788,2618,3038,783,471,26027,6472,8871,5832,960,79888,5631,6576,4907,3992,29968,10243,56895,6916,5682,3615,23236,51129,5226,57761,2110,51,1462,51586,6834,3099,6566,6713,1800,6907,4725,1717,132,9653	SRM,CYP24A1,GGT1,TNFRSF21,PPARGC1B,CEMIP,SLC52A3,UROD,LPCAT3,ARSJ,PRKCA,HMOX2,COX10,SYNJ1,NUP160,LCLAT1,FLAD1,IDI1,ASNS,SREBF2,LPIN2,HYAL1,ME1,NT5C,MGLL,GNG5,PRKACB,CHD9,PPARG,UPP1,GPCPD1,COL4A3BP,PITPNB,ODC1,MGST1,GNAI1,PYCR1,PLIN2,GNG2,GLS,HPRT1,INSIG1,HLCS,ALAD,ABCC3,XYLB,NOSTRIN,AK2,SULT1C2,SEC24D,GPAT3,PRSS3,MED13L,SLC25A12,PLA2G12A,APRT,PIP4K2A,SLC25A20,GART,HAS3,CACNB2,ATIC,ACOT11,SHMT2,SYNJ2,ALDH18A1,CD44,LPCAT1,PRPS1,SLC25A1,NT5E,FADS1,PSAT1,GPHN,AGPAT4,TBXAS1,PSMA1,IMPDH2,PLCB1,ANGPTL4,PGD,TRIB3,ETFDH,ACOX1,VCAN,MED15,SURF1,HK2,SLC16A1,SQLE,DPEP1,TBL1X,NDUFS5,DHCR7,ADK,HS2ST1
R-HSA-1483206	Glycerophospholipid biosynthesis	0.0126616050103817	-4.36918109223055	96	10	0.0264550264550265	378	8202	56895,84803,56261,9663,10162,81579,23760,253558,11343,79888	AGPAT4,GPAT3,GPCPD1,LPIN2,LPCAT3,PLA2G12A,PITPNB,LCLAT1,MGLL,LPCAT1
R-HSA-352230	Amino acid transport across the plasma membrane	0.0127844541273462	-4.35952536748635	31	5	0.0132275132275132	378	8202	6541,6520,23657,81539,54407	SLC7A1,SLC3A2,SLC7A11,SLC38A1,SLC38A2
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.014246797117863	-4.25122316118935	21	4	0.0105820105820106	378	8202	10667,79731,23438,2617	FARS2,NARS2,HARS2,GARS
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.0145944988843707	-4.2271106100123	32	5	0.0132275132275132	378	8202	4088,56937,7048,51377,4092	SMAD3,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-190373	FGFR1c ligand binding and activation	0.0156566146736579	-4.15686178843922	12	3	0.00793650793650794	378	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-73621	Pyrimidine catabolism	0.0156566146736579	-4.15686178843922	12	3	0.00793650793650794	378	8202	30833,7378,4907	NT5C,UPP1,NT5E
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.0167943973358035	-4.08670994011018	22	4	0.0105820105820106	378	8202	5984,5983,328,10038	RFC4,RFC3,APEX1,PARP2
R-HSA-1483257	Phospholipid metabolism	0.0170081696510838	-4.07406148265079	146	13	0.0343915343915344	378	8202	56895,84803,56261,9663,81579,10162,23760,8871,253558,11343,8867,79888,5305	AGPAT4,GPAT3,GPCPD1,LPIN2,PLA2G12A,LPCAT3,PITPNB,SYNJ2,LCLAT1,MGLL,SYNJ1,LPCAT1,PIP4K2A
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.0193088191162492	-3.94719333841226	5	2	0.00529100529100529	378	8202	10973,51008	ASCC3,ASCC1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0193088191162492	-3.94719333841226	5	2	0.00529100529100529	378	8202	3038,57214	HAS3,CEMIP
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.0193088191162492	-3.94719333841226	5	2	0.00529100529100529	378	8202	80308,113278	FLAD1,SLC52A3
R-HSA-426048	Arachidonate production from DAG	0.0193088191162492	-3.94719333841226	5	2	0.00529100529100529	378	8202	11343,57406	MGLL,ABHD6
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.0196093791963715	-3.93174729677772	23	4	0.0105820105820106	378	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-3000157	Laminin interactions	0.0196093791963715	-3.93174729677772	23	4	0.0105820105820106	378	8202	3910,3691,3911,3673	LAMA4,ITGB4,LAMA5,ITGA2
R-HSA-74217	Purine salvage	0.0196701742988711	-3.92865178546786	13	3	0.00793650793650794	378	8202	353,3251,132	APRT,HPRT1,ADK
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.0210313862325308	-3.86173937453406	35	5	0.0132275132275132	378	8202	5984,5983,328,10038,4595	RFC4,RFC3,APEX1,PARP2,MUTYH
R-HSA-73884	Base Excision Repair	0.0210313862325308	-3.86173937453406	35	5	0.0132275132275132	378	8202	5984,5983,328,10038,4595	RFC4,RFC3,APEX1,PARP2,MUTYH
R-HSA-4086398	Ca2+ pathway	0.0213875023226082	-3.8449485311673	61	7	0.0185185185185185	378	8202	54331,5578,23236,2787,7976,6934,27327	GNG2,PRKCA,PLCB1,GNG5,FZD3,TCF7L2,TNRC6A
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.0220102454663703	-3.81624723101298	48	6	0.0158730158730159	378	8202	2965,57459,2967,1107,64425,25885	GTF2H1,GATAD2B,GTF2H3,CHD3,POLR1E,POLR1A
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.0226985800069661	-3.78545291121061	24	4	0.0105820105820106	378	8202	2744,6857,10550,54407	GLS,SYT1,ARL6IP5,SLC38A2
R-HSA-5655302	Signaling by FGFR1 in disease	0.0235298201324282	-3.74948672045278	36	5	0.0132275132275132	378	8202	2254,4893,2247,2260,1523	FGF9,NRAS,FGF2,FGFR1,CUX1
R-HSA-2559583	Cellular Senescence	0.0256791755045171	-3.66207490719772	187	15	0.0396825396825397	378	8202	1912,54386,8091,57634,23043,3397,1019,79813,472,22955,648,1021,5606,7324,27327	PHC2,TERF2IP,HMGA2,EP400,TNIK,ID1,CDK4,EHMT1,ATM,SCMH1,BMI1,CDK6,MAP2K3,UBE2E1,TNRC6A
R-HSA-380994	ATF4 activates genes	0.0260676360992602	-3.64706073028183	25	4	0.0105820105820106	378	8202	440,468,5073,9709	ASNS,ATF4,PARN,HERPUD1
R-HSA-425410	Metal ion SLC transporters	0.0260676360992602	-3.64706073028183	25	4	0.0105820105820106	378	8202	23516,30061,7922,148867	SLC39A14,SLC40A1,SLC39A7,SLC30A7
R-HSA-5683057	MAPK family signaling cascades	0.0268642974048504	-3.61695710794995	273	20	0.0529100529100529	378	8202	2254,200734,4893,8831,10435,2335,2308,2247,5786,5682,1742,3570,2260,3667,817,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,CDC42EP2,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,IL6R,FGFR1,IRS1,CAMK2D,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-190370	FGFR1b ligand binding and activation	0.028088146800888	-3.57240761366683	6	2	0.00529100529100529	378	8202	2247,2260	FGF2,FGFR1
R-HSA-73942	DNA Damage Reversal	0.028088146800888	-3.57240761366683	6	2	0.00529100529100529	378	8202	10973,51008	ASCC3,ASCC1
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.028088146800888	-3.57240761366683	6	2	0.00529100529100529	378	8202	4088,7048	SMAD3,TGFBR2
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.0292218464923114	-3.53283868190081	65	7	0.0185185185185185	378	8202	2965,2967,6827,6872,83860,6924,51616	GTF2H1,GTF2H3,SUPT4H1,TAF1,TAF3,TCEB3,TAF9B
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.0292348594624748	-3.53239346453299	15	3	0.00793650793650794	378	8202	5578,9663,7112	PRKCA,LPIN2,TMPO
R-HSA-264876	Insulin processing	0.0297210020651228	-3.51590134283951	26	4	0.0105820105820106	378	8202	3800,3798,60412,148867	KIF5C,KIF5A,EXOC4,SLC30A7
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.0297210020651228	-3.51590134283951	26	4	0.0105820105820106	378	8202	2254,4893,6464,2247	FGF9,NRAS,SHC1,FGF2
R-HSA-162599	Late Phase of HIV Life Cycle	0.0321168071167595	-3.4383757996777	127	11	0.0291005291005291	378	8202	2967,6827,6872,83860,8731,79720,6924,2965,23279,51616,92421	GTF2H3,SUPT4H1,TAF1,TAF3,RNMT,VPS37B,TCEB3,GTF2H1,NUP160,TAF9B,CHMP4C
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.0321434621599887	-3.43754620325497	39	5	0.0132275132275132	378	8202	472,5984,672,5983,5890	ATM,RFC4,BRCA1,RFC3,RAD51B
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.0321434621599887	-3.43754620325497	39	5	0.0132275132275132	378	8202	54901,93587,54482,55253,91801	CDKAL1,TRMT10A,TRMT13,TYW1,ALKBH8
R-HSA-109582	Hemostasis	0.0329163528488416	-3.41378569762054	515	33	0.0873015873015873	378	8202	7273,2335,3798,5578,57406,5139,5583,10019,6464,6281,23657,10846,960,3273,11343,7414,2787,5567,285,4893,6520,5138,5140,7114,2770,1525,54331,2627,3673,5890,6566,1191,5152	TTN,FN1,KIF5A,PRKCA,ABHD6,PDE3A,PRKCH,SH2B3,SHC1,S100A10,SLC7A11,PDE10A,CD44,HRG,MGLL,VCL,GNG5,PRKACB,ANGPT2,NRAS,SLC3A2,PDE2A,PDE3B,TMSB4X,GNAI1,CXADR,GNG2,GATA6,ITGA2,RAD51B,SLC16A1,CLU,PDE9A
R-HSA-1433559	Regulation of KIT signaling	0.0347823306211309	-3.3586457619178	16	3	0.00793650793650794	378	8202	10019,8651,5578	SH2B3,SOCS1,PRKCA
R-HSA-190242	FGFR1 ligand binding and activation	0.0347823306211309	-3.3586457619178	16	3	0.00793650793650794	378	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-5696400	Dual Incision in GG-NER	0.035398644627425	-3.34108174693626	40	5	0.0132275132275132	378	8202	2965,2967,5984,5983,10038	GTF2H1,GTF2H3,RFC4,RFC3,PARP2
R-HSA-75109	Triglyceride Biosynthesis	0.0362327780880568	-3.31779109779717	68	7	0.0185185185185185	378	8202	79888,253558,56895,84803,9663,6576,26027	LPCAT1,LCLAT1,AGPAT4,GPAT3,LPIN2,SLC25A1,ACOT11
R-HSA-177929	Signaling by EGFR	0.0367439689568103	-3.30378117680958	336	23	0.0608465608465608	378	8202	2254,200734,5829,4893,8831,2335,2308,2247,5786,5682,1742,5578,55824,2260,3667,57761,817,6464,7414,5567,27327,6709,5796	FGF9,SPRED2,PXN,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,PAG1,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKACB,TNRC6A,SPTAN1,PTPRK
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.0378927416634866	-3.27299569807145	28	4	0.0105820105820106	378	8202	54331,783,2787,2770	GNG2,CACNB2,GNG5,GNAI1
R-HSA-381042	PERK regulates gene expression	0.0378927416634866	-3.27299569807145	28	4	0.0105820105820106	378	8202	440,468,5073,9709	ASNS,ATF4,PARN,HERPUD1
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.0381400271083546	-3.26649096805095	7	2	0.00529100529100529	378	8202	4088,7048	SMAD3,TGFBR2
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.0381400271083546	-3.26649096805095	7	2	0.00529100529100529	378	8202	4088,7048	SMAD3,TGFBR2
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.0381400271083546	-3.26649096805095	7	2	0.00529100529100529	378	8202	328,10038	APEX1,PARP2
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.0381400271083546	-3.26649096805095	7	2	0.00529100529100529	378	8202	4088,7048	SMAD3,TGFBR2
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.0381400271083546	-3.26649096805095	7	2	0.00529100529100529	378	8202	4088,7048	SMAD3,TGFBR2
R-HSA-202733	Cell surface interactions at the vascular wall	0.03836740968801	-3.26054688578474	99	9	0.0238095238095238	378	8202	6520,4893,2335,6464,23657,6566,960,285,1525	SLC3A2,NRAS,FN1,SHC1,SLC7A11,SLC16A1,CD44,ANGPT2,CXADR
R-HSA-435354	Zinc transporters	0.0408318642828593	-3.19829251505895	17	3	0.00793650793650794	378	8202	23516,7922,148867	SLC39A14,SLC39A7,SLC30A7
R-HSA-1839124	FGFR1 mutant receptor activation	0.0424143900212946	-3.16026758702838	29	4	0.0105820105820106	378	8202	2254,2247,2260,1523	FGF9,FGF2,FGFR1,CUX1
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.0425001386766638	-3.15824794007677	42	5	0.0132275132275132	378	8202	472,5984,672,5983,5890	ATM,RFC4,BRCA1,RFC3,RAD51B
R-HSA-1433557	Signaling by SCF-KIT	0.0449156972771845	-3.10296794004911	307	21	0.0555555555555556	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,10019,817,57761,6464,8651,7414,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,SH2B3,CAMK2D,TRIB3,SHC1,SOCS1,VCL,TNRC6A,SPTAN1
R-HSA-180292	GAB1 signalosome	0.045088526392022	-3.09912746856419	102	9	0.0238095238095238	378	8202	3667,57761,2254,5829,2308,2247,55824,2260,27327	IRS1,TRIB3,FGF9,PXN,FOXO1,FGF2,PAG1,FGFR1,TNRC6A
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.0460863204090616	-3.07723911034532	1	1	0.00264550264550265	378	8202	2260	FGFR1
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.0460863204090616	-3.07723911034532	1	1	0.00264550264550265	378	8202	23760	PITPNB
R-HSA-2559585	Oncogene Induced Senescence	0.0472269799300034	-3.05278994101013	30	4	0.0105820105820106	378	8202	3397,1021,1019,27327	ID1,CDK6,CDK4,TNRC6A
R-HSA-210993	Tie2 Signaling	0.0473738849222151	-3.0496841531185	18	3	0.00793650793650794	378	8202	4893,6464,285	NRAS,SHC1,ANGPT2
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.0493291579776289	-3.00923993305653	8	2	0.00529100529100529	378	8202	4088,7048	SMAD3,TGFBR2
R-HSA-73772	RNA Polymerase I Promoter Escape	0.0523295763448345	-2.95019355446808	31	4	0.0105820105820106	378	8202	2965,2967,64425,25885	GTF2H1,GTF2H3,POLR1E,POLR1A
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.0543964251312256	-2.91145684177906	19	3	0.00793650793650794	378	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-1226099	Signaling by FGFR in disease	0.0546522046628582	-2.90676572367542	45	5	0.0132275132275132	378	8202	2254,4893,2247,2260,1523	FGF9,NRAS,FGF2,FGFR1,CUX1
R-HSA-4839726	Chromatin organization	0.0565478460619963	-2.87266816623478	261	18	0.0476190476190476	378	8202	51780,57459,57634,10765,55904,1019,84159,79813,58508,57492,317772,23587,1107,6907,55689,23081,8819,7994	KDM3B,GATAD2B,EP400,KDM5B,KMT2E,CDK4,ARID5B,EHMT1,KMT2C,ARID1B,HIST2H2AB,ELP5,CHD3,TBL1X,YEATS2,KDM4C,SAP30,KAT6A
R-HSA-3247509	Chromatin modifying enzymes	0.0565478460619963	-2.87266816623478	261	18	0.0476190476190476	378	8202	51780,57459,57634,10765,55904,1019,84159,79813,58508,57492,317772,23587,1107,6907,55689,23081,8819,7994	KDM3B,GATAD2B,EP400,KDM5B,KMT2E,CDK4,ARID5B,EHMT1,KMT2C,ARID1B,HIST2H2AB,ELP5,CHD3,TBL1X,YEATS2,KDM4C,SAP30,KAT6A
R-HSA-74160	Gene Expression	0.0570167330175564	-2.86441049251688	1330	73	0.193121693121693	378	8202	9534,51123,25885,5578,23279,16,93587,8565,27339,8819,79731,80205,2617,7748,340252,5468,8731,3035,2649,6924,4774,5451,29115,1207,7453,51616,25929,4088,2744,6498,6827,1107,28996,2521,80746,8891,27327,833,6872,4092,10667,10946,10644,677,6748,5073,10643,54541,93134,54807,83860,54482,91801,2965,23438,64425,10302,57459,171392,10780,2967,55253,5682,4141,6897,7025,3304,10940,51586,6834,80264,54901,6907	ZNF254,ZNF706,POLR1A,PRKCA,NUP160,AARS,TRMT10A,YARS,PRPF19,SAP30,NARS2,CHD9,GARS,ZNF195,ZNF680,PPARG,RNMT,HARS,NR6A1,TCEB3,NFIA,POU2F1,SAP30BP,CLNS1A,WARS,TAF9B,GEMIN5,SMAD3,GLS,SKIL,SUPT4H1,CHD3,HIPK2,FUS,TSEN2,EIF2B3,TNRC6A,CARS,TAF1,SMAD7,FARS2,SF3A3,IGF2BP2,ZFP36L1,SSR4,PARN,IGF2BP3,DDIT4,ZNF561,ZNF586,TAF3,TRMT13,ALKBH8,GTF2H1,HARS2,POLR1E,SNAPC5,GATAD2B,ZNF675,ZNF234,GTF2H3,TYW1,PSMA1,MARS,TARS,NR2F1,HSPA1B,POP1,MED15,SURF1,ZNF430,CDKAL1,TBL1X
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.0577203016966206	-2.85214631819095	32	4	0.0105820105820106	378	8202	1742,54331,23236,2787	DLG4,GNG2,PLCB1,GNG5
R-HSA-73863	RNA Polymerase I Transcription Termination	0.0577203016966206	-2.85214631819095	32	4	0.0105820105820106	378	8202	2965,2967,64425,25885	GTF2H1,GTF2H3,POLR1E,POLR1A
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.0591054670750184	-2.82843185334899	46	5	0.0132275132275132	378	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-73776	RNA Polymerase II Promoter Escape	0.0591054670750184	-2.82843185334899	46	5	0.0132275132275132	378	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-167161	HIV Transcription Initiation	0.0591054670750184	-2.82843185334899	46	5	0.0132275132275132	378	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.0591054670750184	-2.82843185334899	46	5	0.0132275132275132	378	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.0591054670750184	-2.82843185334899	46	5	0.0132275132275132	378	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-418597	G alpha (z) signalling events	0.0591054670750184	-2.82843185334899	46	5	0.0132275132275132	378	8202	54331,5583,5578,2787,2770	GNG2,PRKCH,PRKCA,GNG5,GNAI1
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.0591054670750184	-2.82843185334899	46	5	0.0132275132275132	378	8202	2965,2967,6872,83860,51616	GTF2H1,GTF2H3,TAF1,TAF3,TAF9B
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.0615299495162422	-2.78823123870395	9	2	0.00529100529100529	378	8202	328,4595	APEX1,MUTYH
R-HSA-162592	Integration of provirus	0.0615299495162422	-2.78823123870395	9	2	0.00529100529100529	378	8202	3836,7518	KPNA1,XRCC4
R-HSA-2179392	EGFR Transactivation by Gastrin	0.0615299495162422	-2.78823123870395	9	2	0.00529100529100529	378	8202	4893,5578	NRAS,PRKCA
R-HSA-446107	Type I hemidesmosome assembly	0.0615299495162422	-2.78823123870395	9	2	0.00529100529100529	378	8202	667,3691	DST,ITGB4
R-HSA-447041	CHL1 interactions	0.0615299495162422	-2.78823123870395	9	2	0.00529100529100529	378	8202	8829,3673	NRP1,ITGA2
R-HSA-2428933	SHC-related events triggered by IGF1R	0.0615299495162422	-2.78823123870395	9	2	0.00529100529100529	378	8202	4893,6464	NRAS,SHC1
R-HSA-418217	G beta:gamma signalling through PLC beta	0.0618854654305925	-2.78246993412334	20	3	0.00793650793650794	378	8202	54331,23236,2787	GNG2,PLCB1,GNG5
R-HSA-69190	DNA strand elongation	0.0633963876075644	-2.75834839696092	33	4	0.0105820105820106	378	8202	5984,5983,328,4174	RFC4,RFC3,APEX1,MCM5
R-HSA-418346	Platelet homeostasis	0.0672327474148802	-2.69959483742988	78	7	0.0185185185185185	378	8202	54331,5138,5140,10846,2787,5152,5139	GNG2,PDE2A,PDE3B,PDE10A,GNG5,PDE9A,PDE3A
R-HSA-72306	tRNA processing	0.0675802253120491	-2.69443986369668	94	8	0.0211640211640212	378	8202	10940,54482,55253,91801,54901,80746,93587,23279	POP1,TRMT13,TYW1,ALKBH8,CDKAL1,TSEN2,TRMT10A,NUP160
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.0693542280587597	-2.6685281671185	34	4	0.0105820105820106	378	8202	9140,7187,3093,9636	ATG12,TRAF3,UBE2K,ISG15
R-HSA-500657	Presynaptic function of Kainate receptors	0.0698252434839732	-2.66175968009685	21	3	0.00793650793650794	378	8202	54331,23236,2787	GNG2,PLCB1,GNG5
R-HSA-69186	Lagging Strand Synthesis	0.0698252434839732	-2.66175968009685	21	3	0.00793650793650794	378	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.0736680561983429	-2.60818600388944	49	5	0.0132275132275132	378	8202	2254,5578,2247,2260,5567	FGF9,PRKCA,FGF2,FGFR1,PRKACB
R-HSA-5684996	MAPK1/MAPK3 signaling	0.0737234052832952	-2.6074349551245	234	16	0.0423280423280423	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,3570,2260,3667,817,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,IL6R,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-74259	Purine catabolism	0.0746259199653425	-2.59526737950157	10	2	0.00529100529100529	378	8202	30833,4907	NT5C,NT5E
R-HSA-74749	Signal attenuation	0.0746259199653425	-2.59526737950157	10	2	0.00529100529100529	378	8202	3667,6464	IRS1,SHC1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.0746259199653425	-2.59526737950157	10	2	0.00529100529100529	378	8202	23516,7922	SLC39A14,SLC39A7
R-HSA-399997	Acetylcholine regulates insulin secretion	0.0746259199653425	-2.59526737950157	10	2	0.00529100529100529	378	8202	5578,23236	PRKCA,PLCB1
R-HSA-422356	Regulation of insulin secretion	0.0748976927954116	-2.59163219273299	80	7	0.0185185185185185	378	8202	54331,5578,23236,783,2787,5567,2770	GNG2,PRKCA,PLCB1,CACNB2,GNG5,PRKACB,GNAI1
R-HSA-1266738	Developmental Biology	0.0757853635316118	-2.57985009822922	710	41	0.108465608465608	378	8202	1948,6938,200734,26052,2335,2308,5786,7204,23389,5087,55740,6464,6721,783,5962,7414,6709,2254,80205,4893,51466,8831,2649,5468,2247,1019,287,5682,1742,23365,51129,2260,4088,3667,817,51586,3673,6907,7026,8829,4208	EFNB2,TCF12,SPRED2,DNM3,FN1,FOXO1,PTPRA,TRIO,MED13L,PBX1,ENAH,SHC1,SREBF2,CACNB2,RDX,VCL,SPTAN1,FGF9,CHD9,NRAS,EVL,SYNGAP1,NR6A1,PPARG,FGF2,CDK4,ANK2,PSMA1,DLG4,ARHGEF12,ANGPTL4,FGFR1,SMAD3,IRS1,CAMK2D,MED15,ITGA2,TBL1X,NR2F2,NRP1,MEF2C
R-HSA-373760	L1CAM interactions	0.0781142458382479	-2.54958283367108	97	8	0.0211640211640212	378	8202	26052,287,3673,1742,5962,8829,2260,6709	DNM3,ANK2,ITGA2,DLG4,RDX,NRP1,FGFR1,SPTAN1
R-HSA-5423646	Aflatoxin activation and detoxification	0.0781985349800799	-2.54850436587644	22	3	0.00793650793650794	378	8202	2678,1800,4257	GGT1,DPEP1,MGST1
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.0781985349800799	-2.54850436587644	22	3	0.00793650793650794	378	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-5655332	Signaling by FGFR3 in disease	0.0781985349800799	-2.54850436587644	22	3	0.00793650793650794	378	8202	2254,4893,2247	FGF9,NRAS,FGF2
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.0781985349800799	-2.54850436587644	22	3	0.00793650793650794	378	8202	5947,157506,4647	RBP1,RDH10,MYO7A
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.0789153829030377	-2.53937910304853	81	7	0.0185185185185185	378	8202	9140,7187,4793,3093,10010,9636,843	ATG12,TRAF3,NFKBIB,UBE2K,TANK,ISG15,CASP10
R-HSA-5654716	Downstream signaling of activated FGFR4	0.079802354746394	-2.52820226686155	310	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-5654687	Downstream signaling of activated FGFR1	0.079802354746394	-2.52820226686155	310	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-5654708	Downstream signaling of activated FGFR3	0.079802354746394	-2.52820226686155	310	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.079802354746394	-2.52820226686155	310	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-1643685	Disease	0.0837070098516331	-2.48043255527269	657	38	0.100529100529101	378	8202	2308,6872,54894,162,7048,23279,5606,182,6464,83860,2965,2967,2254,4893,2247,8731,6924,1523,5682,6857,9636,2260,6934,3304,22943,51616,3667,4088,3836,6827,1462,79720,7187,6907,4793,7518,5947,92421	FOXO1,TAF1,RNF43,AP1B1,TGFBR2,NUP160,MAP2K3,JAG1,SHC1,TAF3,GTF2H1,GTF2H3,FGF9,NRAS,FGF2,RNMT,TCEB3,CUX1,PSMA1,SYT1,ISG15,FGFR1,TCF7L2,HSPA1B,DKK1,TAF9B,IRS1,SMAD3,KPNA1,SUPT4H1,VCAN,VPS37B,TRAF3,TBL1X,NFKBIB,XRCC4,RBP1,CHMP4C
R-HSA-162906	HIV Infection	0.0855384879444369	-2.45878885293024	221	15	0.0396825396825397	378	8202	2967,3836,6827,6872,83860,8731,79720,6924,5682,2965,162,7518,23279,51616,92421	GTF2H3,KPNA1,SUPT4H1,TAF1,TAF3,RNMT,VPS37B,TCEB3,PSMA1,GTF2H1,AP1B1,XRCC4,NUP160,TAF9B,CHMP4C
R-HSA-5654741	Signaling by FGFR3	0.0859776729834227	-2.45366763290665	313	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-5654743	Signaling by FGFR4	0.0859776729834227	-2.45366763290665	313	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-191273	Cholesterol biosynthesis	0.0869869083479866	-2.44199765040939	23	3	0.00793650793650794	378	8202	6713,3422,1717	SQLE,IDI1,DHCR7
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.0869869083479866	-2.44199765040939	23	3	0.00793650793650794	378	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-5654736	Signaling by FGFR1	0.0881042333095198	-2.42923469600805	314	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.0888707897884446	-2.42057176426275	37	4	0.0105820105820106	378	8202	472,5984,672,5983	ATM,RFC4,BRCA1,RFC3
R-HSA-176187	Activation of ATR in response to replication stress	0.0888707897884446	-2.42057176426275	37	4	0.0105820105820106	378	8202	5984,5983,55388,4174	RFC4,RFC3,MCM10,MCM5
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.0900540524989294	-2.40734520560842	2	1	0.00264550264550265	378	8202	3304	HSPA1B
R-HSA-141424	Amplification of signal from the kinetochores	0.0900540524989294	-2.40734520560842	2	1	0.00264550264550265	378	8202	8379	MAD1L1
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.0900540524989294	-2.40734520560842	2	1	0.00264550264550265	378	8202	7048	TGFBR2
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.0900540524989294	-2.40734520560842	2	1	0.00264550264550265	378	8202	8379	MAD1L1
R-HSA-165160	PDE3B signalling	0.0900540524989294	-2.40734520560842	2	1	0.00264550264550265	378	8202	5140	PDE3B
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.0900540524989294	-2.40734520560842	2	1	0.00264550264550265	378	8202	328	APEX1
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.0901315830692914	-2.40648464227991	241	16	0.0423280423280423	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,5578,2260,3667,817,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-111885	Opioid Signalling	0.0917057972265564	-2.38916968223536	84	7	0.0185185185185185	378	8202	54331,5578,23236,2787,5567,5142,2770	GNG2,PRKCA,PLCB1,GNG5,PRKACB,PDE4B,GNAI1
R-HSA-5654738	Signaling by FGFR2	0.0924601447515925	-2.3809775948642	316	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-166520	Signalling by NGF	0.0931448514459867	-2.3735994551101	430	26	0.0687830687830688	378	8202	2254,200734,26052,4893,8831,2335,2308,2247,5786,7204,5682,1742,84033,57142,23365,5578,2260,3667,57761,817,6464,7414,5567,27327,4208,6709	FGF9,SPRED2,DNM3,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,TRIO,PSMA1,DLG4,OBSCN,RTN4,ARHGEF12,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKACB,TNRC6A,MEF2C,SPTAN1
R-HSA-190236	Signaling by FGFR	0.0946896637818783	-2.35715043171773	317	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.0954404583991616	-2.34925269819519	355	22	0.0582010582010582	378	8202	2254,200734,26052,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,57761,817,6464,7414,5567,27327,4208,6709	FGF9,SPRED2,DNM3,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,TRIB3,CAMK2D,SHC1,VCL,PRKACB,TNRC6A,MEF2C,SPTAN1
R-HSA-73848	Pyrimidine metabolism	0.096170955253552	-2.34162788733888	24	3	0.00793650793650794	378	8202	30833,7378,4907	NT5C,UPP1,NT5E
R-HSA-2132295	MHC class II antigen presentation	0.0977329586350745	-2.32551643152906	102	8	0.0211640211640212	378	8202	1778,26052,9871,3798,51164,79659,162,114876	DYNC1H1,DNM3,SEC24D,KIF5A,DCTN4,DYNC2H1,AP1B1,OSBPL1A
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.100841262716387	-2.29420765476157	86	7	0.0185185185185185	378	8202	7273,1191,2335,3273,5578,7414,7114	TTN,CLU,FN1,HRG,PRKCA,VCL,TMSB4X
R-HSA-194138	Signaling by VEGF	0.101585265886253	-2.28685677515888	320	20	0.0529100529100529	378	8202	2254,200734,5829,4893,8831,2335,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,8829,7414,5567,6709	FGF9,SPRED2,PXN,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,NRP1,VCL,PRKACB,SPTAN1
R-HSA-1227986	Signaling by ERBB2	0.101585265886253	-2.28685677515888	320	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.103079628849647	-2.27225349380936	12	2	0.00529100529100529	378	8202	7431,6709	VIM,SPTAN1
R-HSA-2160916	Hyaluronan uptake and degradation	0.103079628849647	-2.27225349380936	12	2	0.00529100529100529	378	8202	3373,960	HYAL1,CD44
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.103079628849647	-2.27225349380936	12	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-190239	FGFR3 ligand binding and activation	0.103079628849647	-2.27225349380936	12	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-2033514	FGFR3 mutant receptor activation	0.103079628849647	-2.27225349380936	12	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-190372	FGFR3c ligand binding and activation	0.103079628849647	-2.27225349380936	12	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.104327358747815	-2.2602216431477	228	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.104327358747815	-2.2602216431477	228	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-180336	SHC1 events in EGFR signaling	0.104327358747815	-2.2602216431477	228	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-5673001	RAF/MAP kinase cascade	0.104327358747815	-2.2602216431477	228	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,2335,6464,8831,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,FN1,SHC1,SYNGAP1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-179812	GRB2 events in EGFR signaling	0.104327358747815	-2.2602216431477	228	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-112412	SOS-mediated signalling	0.104327358747815	-2.2602216431477	228	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.104327358747815	-2.2602216431477	228	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-112315	Transmission across Chemical Synapses	0.105212438040604	-2.25177375334228	210	14	0.037037037037037	378	8202	2744,54331,817,81539,10550,783,54407,1742,5578,6857,23236,2787,5567,2770	GLS,GNG2,CAMK2D,SLC38A1,ARL6IP5,CACNB2,SLC38A2,DLG4,PRKCA,SYT1,PLCB1,GNG5,PRKACB,GNAI1
R-HSA-1482788	Acyl chain remodelling of PC	0.10573049877638	-2.24686188679513	25	3	0.00793650793650794	378	8202	81579,10162,79888	PLA2G12A,LPCAT3,LPCAT1
R-HSA-210991	Basigin interactions	0.10573049877638	-2.24686188679513	25	3	0.00793650793650794	378	8202	6566,6520,23657	SLC16A1,SLC3A2,SLC7A11
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.106295497071525	-2.24153235510038	104	8	0.0211640211640212	378	8202	3667,57761,2254,6464,2308,2247,2260,27327	IRS1,TRIB3,FGF9,SHC1,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-186763	Downstream signal transduction	0.106355322514161	-2.24096969144047	322	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.107202815810983	-2.23303276379691	229	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.107202815810983	-2.23303276379691	229	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.107202815810983	-2.23303276379691	229	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.107202815810983	-2.23303276379691	229	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-69481	G2/M Checkpoints	0.110727725644467	-2.20068101313386	105	8	0.0211640211640212	378	8202	8924,5984,9577,5983,55388,4174,472,672	HERC2,RFC4,BRE,RFC3,MCM10,MCM5,ATM,BRCA1
R-HSA-5663202	Diseases of signal transduction	0.112547193611561	-2.18438264653324	268	17	0.044973544973545	378	8202	2254,4893,2308,2247,1523,5682,54894,7048,2260,6934,22943,3667,4088,182,6464,6907,5947	FGF9,NRAS,FOXO1,FGF2,CUX1,PSMA1,RNF43,TGFBR2,FGFR1,TCF7L2,DKK1,IRS1,SMAD3,JAG1,SHC1,TBL1X,RBP1
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.11353899488643	-2.17560893378509	72	6	0.0158730158730159	378	8202	4088,6498,56937,7048,51377,4092	SMAD3,SKIL,PMEPA1,TGFBR2,UCHL5,SMAD7
R-HSA-2424491	DAP12 signaling	0.113770314837333	-2.17357364512017	325	20	0.0529100529100529	378	8202	2254,200734,4893,2335,8831,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,FN1,SYNGAP1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.115644780955693	-2.15723201924609	26	3	0.00793650793650794	378	8202	472,672,5890	ATM,BRCA1,RAD51B
R-HSA-170984	ARMS-mediated activation	0.116115700026078	-2.15316817094472	232	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-187706	Signalling to p38 via RIT and RIN	0.116115700026078	-2.15316817094472	232	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-194840	Rho GTPase cycle	0.118053554221849	-2.13661690813723	124	9	0.0238095238095238	378	8202	23092,58480,93663,7204,84033,101928168,23365,100288637,5881	ARHGAP26,RHOU,ARHGAP18,TRIO,OBSCN,LOC101928168,ARHGEF12,LOC100288637,RAC3
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.118244984221442	-2.1349966692417	13	2	0.00529100529100529	378	8202	3992,51	FADS1,ACOX1
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.118244984221442	-2.1349966692417	13	2	0.00529100529100529	378	8202	3992,51	FADS1,ACOX1
R-HSA-75205	Dissolution of Fibrin Clot	0.118244984221442	-2.1349966692417	13	2	0.00529100529100529	378	8202	3273,6281	HRG,S100A10
R-HSA-190375	FGFR2c ligand binding and activation	0.118244984221442	-2.1349966692417	13	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-170968	Frs2-mediated activation	0.119181880460118	-2.12710454546828	233	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-73857	RNA Polymerase II Transcription	0.119890031102513	-2.12118036383719	107	8	0.0211640211640212	378	8202	2967,6827,8731,6872,83860,6924,2965,51616	GTF2H3,SUPT4H1,RNMT,TAF1,TAF3,TCEB3,GTF2H1,TAF9B
R-HSA-169893	Prolonged ERK activation events	0.12545633331862	-2.07579752264036	235	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-114508	Effects of PIP2 hydrolysis	0.125892631356793	-2.07232586739054	27	3	0.00793650793650794	378	8202	5583,11343,57406	PRKCH,MGLL,ABHD6
R-HSA-5655253	Signaling by FGFR2 in disease	0.125892631356793	-2.07232586739054	27	3	0.00793650793650794	378	8202	2254,4893,2247	FGF9,NRAS,FGF2
R-HSA-1368082	RORA activates gene expression	0.125892631356793	-2.07232586739054	27	3	0.00793650793650794	378	8202	80205,6907,8204	CHD9,TBL1X,NRIP1
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.12649387599141	-2.06756138312152	42	4	0.0105820105820106	378	8202	80205,6907,133522,4208	CHD9,TBL1X,PPARGC1B,MEF2C
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.12649387599141	-2.06756138312152	42	4	0.0105820105820106	378	8202	80205,6907,8204,25819	CHD9,TBL1X,NRIP1,NOCT
R-HSA-2586552	Signaling by Leptin	0.128664286028697	-2.05054870072423	236	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.129871981082511	-2.04120607462589	312	19	0.0502645502645503	378	8202	2254,200734,5829,4893,8831,2335,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,6709	FGF9,SPRED2,PXN,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,SPTAN1
R-HSA-418555	G alpha (s) signalling events	0.131271501346313	-2.03048757114596	127	9	0.0238095238095238	378	8202	3363,54331,10846,5142,5138,5140,2787,5139,2770	HTR7,GNG2,PDE10A,PDE4B,PDE2A,PDE3B,GNG5,PDE3A,GNAI1
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	4595	MUTYH
R-HSA-1483152	Hydrolysis of LPE	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	56261	GPCPD1
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	200894	ARL13B
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	4121	MAN1A1
R-HSA-111458	Formation of apoptosome	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	317	APAF1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	5631	PRPS1
R-HSA-977347	Serine biosynthesis	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	29968	PSAT1
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	4088	SMAD3
R-HSA-110331	Cleavage of the damaged purine	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	4595	MUTYH
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	6934	TCF7L2
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	2260	FGFR1
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-5602571	TRAF3 deficiency - HSE	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	7187	TRAF3
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	4088	SMAD3
R-HSA-73927	Depurination	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	4595	MUTYH
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.132000341297352	-2.02495077081311	3	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-162594	Early Phase of HIV Life Cycle	0.13391977133236	-2.01051437973676	14	2	0.00529100529100529	378	8202	3836,7518	KPNA1,XRCC4
R-HSA-2024101	CS/DS degradation	0.13391977133236	-2.01051437973676	14	2	0.00529100529100529	378	8202	3373,1462	HYAL1,VCAN
R-HSA-190322	FGFR4 ligand binding and activation	0.13391977133236	-2.01051437973676	14	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.13391977133236	-2.01051437973676	14	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-69091	Polymerase switching	0.13391977133236	-2.01051437973676	14	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-877312	Regulation of IFNG signaling	0.13391977133236	-2.01051437973676	14	2	0.00529100529100529	378	8202	8651,3460	SOCS1,IFNGR2
R-HSA-69109	Leading Strand Synthesis	0.13391977133236	-2.01051437973676	14	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.134713775924598	-2.00460292964001	43	4	0.0105820105820106	378	8202	2965,2967,6827,6924	GTF2H1,GTF2H3,SUPT4H1,TCEB3
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.134713775924598	-2.00460292964001	43	4	0.0105820105820106	378	8202	2965,2967,6827,6924	GTF2H1,GTF2H3,SUPT4H1,TCEB3
R-HSA-917937	Iron uptake and transport	0.134713775924598	-2.00460292964001	43	4	0.0105820105820106	378	8202	535,30061,3163,28982	ATP6V0A1,SLC40A1,HMOX2,FLVCR1
R-HSA-167169	HIV Transcription Elongation	0.134713775924598	-2.00460292964001	43	4	0.0105820105820106	378	8202	2965,2967,6827,6924	GTF2H1,GTF2H3,SUPT4H1,TCEB3
R-HSA-912526	Interleukin receptor SHC signaling	0.135220686401636	-2.00084712114823	238	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,2335,6464,8831,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,FN1,SHC1,SYNGAP1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.136452618122416	-1.99177784459951	28	3	0.00793650793650794	378	8202	5984,5983,56852	RFC4,RFC3,RAD18
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.136452618122416	-1.99177784459951	28	3	0.00793650793650794	378	8202	2965,2967,8731	GTF2H1,GTF2H3,RNMT
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.136452618122416	-1.99177784459951	28	3	0.00793650793650794	378	8202	2965,2967,8731	GTF2H1,GTF2H3,RNMT
R-HSA-202040	G-protein activation	0.136452618122416	-1.99177784459951	28	3	0.00793650793650794	378	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-167044	Signalling to RAS	0.138568688043088	-1.97638913374423	239	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-112399	IRS-mediated signalling	0.139094411926671	-1.97260235392461	277	17	0.044973544973545	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.143145117394945	-1.94389635633306	44	4	0.0105820105820106	378	8202	2965,2967,6827,6924	GTF2H1,GTF2H3,SUPT4H1,TCEB3
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.143145117394945	-1.94389635633306	44	4	0.0105820105820106	378	8202	2965,2967,6827,6924	GTF2H1,GTF2H3,SUPT4H1,TCEB3
R-HSA-112382	Formation of RNA Pol II elongation complex	0.143145117394945	-1.94389635633306	44	4	0.0105820105820106	378	8202	2965,2967,6827,6924	GTF2H1,GTF2H3,SUPT4H1,TCEB3
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.147303182902987	-1.91526234744431	29	3	0.00793650793650794	378	8202	80205,6907,28996	CHD9,TBL1X,HIPK2
R-HSA-180786	Extension of Telomeres	0.147303182902987	-1.91526234744431	29	3	0.00793650793650794	378	8202	5984,5983,328	RFC4,RFC3,APEX1
R-HSA-74751	Insulin receptor signalling cascade	0.148675097400936	-1.90599190826317	280	17	0.044973544973545	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.150025142387848	-1.89695238301287	15	2	0.00529100529100529	378	8202	4893,6464	NRAS,SHC1
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.150025142387848	-1.89695238301287	15	2	0.00529100529100529	378	8202	4893,6464	NRAS,SHC1
R-HSA-2428924	IGF1R signaling cascade	0.151948346901439	-1.88421463890564	281	17	0.044973544973545	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.151948346901439	-1.88421463890564	281	17	0.044973544973545	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.151948346901439	-1.88421463890564	281	17	0.044973544973545	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-2172127	DAP12 interactions	0.155486529491805	-1.86119617817754	340	20	0.0529100529100529	378	8202	2254,200734,4893,2335,8831,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,FN1,SYNGAP1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-2262752	Cellular responses to stress	0.155589056645483	-1.860536999753	379	22	0.0582010582010582	378	8202	8091,57634,23043,3397,9588,1019,475,79813,9140,22955,23279,5606,7324,3304,1912,54386,817,472,648,1021,27327,92421	HMGA2,EP400,TNIK,ID1,PRDX6,CDK4,ATOX1,EHMT1,ATG12,SCMH1,NUP160,MAP2K3,UBE2E1,HSPA1B,PHC2,TERF2IP,CAMK2D,ATM,BMI1,CDK6,TNRC6A,CHMP4C
R-HSA-109704	PI3K Cascade	0.156038292564514	-1.8576538366971	79	6	0.0158730158730159	378	8202	3667,57761,2254,2247,5140,2260	IRS1,TRIB3,FGF9,FGF2,PDE3B,FGFR1
R-HSA-399719	Trafficking of AMPA receptors	0.158422761009448	-1.84248811668323	30	3	0.00793650793650794	378	8202	1742,817,5578	DLG4,CAMK2D,PRKCA
R-HSA-5656169	Termination of translesion DNA synthesis	0.158422761009448	-1.84248811668323	30	3	0.00793650793650794	378	8202	5984,5983,9636	RFC4,RFC3,ISG15
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.158422761009448	-1.84248811668323	30	3	0.00793650793650794	378	8202	1742,817,5578	DLG4,CAMK2D,PRKCA
R-HSA-72086	mRNA Capping	0.158422761009448	-1.84248811668323	30	3	0.00793650793650794	378	8202	2965,2967,8731	GTF2H1,GTF2H3,RNMT
R-HSA-451927	Interleukin-2 signaling	0.159616606755604	-1.83498054702609	245	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,2335,6464,8831,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,FN1,SHC1,SYNGAP1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-112043	PLC beta mediated events	0.160604582317514	-1.82880994538889	46	4	0.0105820105820106	378	8202	5578,23236,5567,2770	PRKCA,PLCB1,PRKACB,GNAI1
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.160604582317514	-1.82880994538889	46	4	0.0105820105820106	378	8202	2254,5578,2247,5567	FGF9,PRKCA,FGF2,PRKACB
R-HSA-73893	DNA Damage Bypass	0.160604582317514	-1.82880994538889	46	4	0.0105820105820106	378	8202	5984,5983,56852,9636	RFC4,RFC3,RAD18,ISG15
R-HSA-187687	Signalling to ERKs	0.163281538065405	-1.81227934072209	246	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,6464,8831,2335,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,SHC1,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-400253	Circadian Clock	0.163783643821304	-1.80920896711976	63	5	0.0132275132275132	378	8202	80205,6907,8204,25819,4208	CHD9,TBL1X,NRIP1,NOCT,MEF2C
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.163783643821304	-1.80920896711976	63	5	0.0132275132275132	378	8202	2965,2967,5984,5983,27339	GTF2H1,GTF2H3,RFC4,RFC3,PRPF19
R-HSA-74752	Signaling by Insulin receptor	0.164319192451943	-1.80594444729825	304	18	0.0476190476190476	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,535,5140,2260,3667,817,57761,6464,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,ATP6V0A1,PDE3B,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1
R-HSA-1250342	PI3K events in ERBB4 signaling	0.165298405938133	-1.80000291764913	98	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-5654720	PI-3K cascade:FGFR4	0.165298405938133	-1.80000291764913	98	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-5654689	PI-3K cascade:FGFR1	0.165298405938133	-1.80000291764913	98	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-5654695	PI-3K cascade:FGFR2	0.165298405938133	-1.80000291764913	98	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-5654710	PI-3K cascade:FGFR3	0.165298405938133	-1.80000291764913	98	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-1257604	PIP3 activates AKT signaling	0.165298405938133	-1.80000291764913	98	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-1963642	PI3K events in ERBB2 signaling	0.165298405938133	-1.80000291764913	98	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-375165	NCAM signaling for neurite out-growth	0.166340219926905	-1.79372007038962	266	16	0.0423280423280423	378	8202	2254,200734,4893,8831,2335,2247,5786,5682,1742,2260,3667,817,6464,783,7414,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,SHC1,CACNB2,VCL,SPTAN1
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.166488401213807	-1.79282963436771	16	2	0.00529100529100529	378	8202	8091,57634	HMGA2,EP400
R-HSA-110312	Translesion synthesis by REV1	0.166488401213807	-1.79282963436771	16	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-446353	Cell-extracellular matrix interactions	0.166488401213807	-1.79282963436771	16	2	0.00529100529100529	378	8202	2318,5829	FLNC,PXN
R-HSA-114608	Platelet degranulation	0.169313410290724	-1.77600378275719	81	6	0.0158730158730159	378	8202	7273,1191,2335,3273,7414,7114	TTN,CLU,FN1,HRG,VCL,TMSB4X
R-HSA-112040	G-protein mediated events	0.169613400079138	-1.77423354884487	47	4	0.0105820105820106	378	8202	5578,23236,5567,2770	PRKCA,PLCB1,PRKACB,GNAI1
R-HSA-70263	Gluconeogenesis	0.169789887937073	-1.77319355966343	31	3	0.00793650793650794	378	8202	8604,5567,6576	SLC25A12,PRKACB,SLC25A1
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.169789887937073	-1.77319355966343	31	3	0.00793650793650794	378	8202	4316,4325,4323	MMP7,MMP16,MMP14
R-HSA-2871796	FCERI mediated MAPK activation	0.170742545404875	-1.76759843943522	248	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,2335,6464,8831,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,FN1,SHC1,SYNGAP1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-73894	DNA Repair	0.171038951654501	-1.76586396096588	306	18	0.0476190476190476	378	8202	8924,2967,5984,51008,5983,328,10038,672,9636,10973,9577,56852,5890,2965,472,7518,4595,27339	HERC2,GTF2H3,RFC4,ASCC1,RFC3,APEX1,PARP2,BRCA1,ISG15,ASCC3,BRE,RAD18,RAD51B,GTF2H1,ATM,XRCC4,MUTYH,PRPF19
R-HSA-186797	Signaling by PDGF	0.171068859939026	-1.76568911383531	345	20	0.0529100529100529	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,5578,2260,3667,817,57761,6464,7414,5567,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,PRKCA,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,PRKACB,TNRC6A,SPTAN1
R-HSA-6782135	Dual incision in TC-NER	0.171442683105212	-1.76350627753557	64	5	0.0132275132275132	378	8202	2965,2967,5984,5983,27339	GTF2H1,GTF2H3,RFC4,RFC3,PRPF19
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.171930092366787	-1.76066732451568	424	24	0.0634920634920635	378	8202	2254,200734,4893,8831,2335,2247,5786,4923,7204,5682,1742,5578,23236,57406,2260,54331,5583,3667,817,6464,7414,11343,2787,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FGF2,PTPRA,NTSR1,TRIO,PSMA1,DLG4,PRKCA,PLCB1,ABHD6,FGFR1,GNG2,PRKCH,IRS1,CAMK2D,SHC1,VCL,MGLL,GNG5,SPTAN1
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	5829	PXN
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	7048	TGFBR2
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	7048	TGFBR2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	81539	SLC38A1
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	5366	PMAIP1
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	7048	TGFBR2
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	8829	NRP1
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	2308	FOXO1
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	328	APEX1
R-HSA-433692	Proton-coupled monocarboxylate transport	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	6566	SLC16A1
R-HSA-165158	Activation of AKT2	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	57761	TRIB3
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.172017888681733	-1.76015680361316	4	1	0.00264550264550265	378	8202	81539	SLC38A1
R-HSA-76002	Platelet activation, signaling and aggregation	0.175194015929615	-1.74186125671605	230	14	0.037037037037037	378	8202	5583,54331,7273,2335,6464,1191,5578,3273,57406,11343,7414,7114,2787,2770	PRKCH,GNG2,TTN,FN1,SHC1,CLU,PRKCA,HRG,ABHD6,MGLL,VCL,TMSB4X,GNG5,GNAI1
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.178795128289251	-1.72151466331833	48	4	0.0105820105820106	378	8202	2254,5578,2247,5567	FGF9,PRKCA,FGF2,PRKACB
R-HSA-3214842	HDMs demethylate histones	0.178795128289251	-1.72151466331833	48	4	0.0105820105820106	378	8202	51780,10765,84159,23081	KDM3B,KDM5B,ARID5B,KDM4C
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.17923787472327	-1.71904144629099	65	5	0.0132275132275132	378	8202	472,5984,672,5983,5890	ATM,RFC4,BRCA1,RFC3,RAD51B
R-HSA-397014	Muscle contraction	0.17923787472327	-1.71904144629099	65	5	0.0132275132275132	378	8202	7134,7431,7273,5829,7414	TNNC1,VIM,TTN,PXN,VCL
R-HSA-392518	Signal amplification	0.181383293410909	-1.70714284360794	32	3	0.00793650793650794	378	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.181383293410909	-1.70714284360794	32	3	0.00793650793650794	378	8202	2254,2247,2260	FGF9,FGF2,FGFR1
R-HSA-2559580	Oxidative Stress Induced Senescence	0.182700292941474	-1.69990821219785	119	8	0.0211640211640212	378	8202	1912,23043,1019,22955,648,1021,5606,27327	PHC2,TNIK,CDK4,SCMH1,BMI1,CDK6,MAP2K3,TNRC6A
R-HSA-2033519	Activated point mutants of FGFR2	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-1839126	FGFR2 mutant receptor activation	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-5656121	Translesion synthesis by POLI	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-5655862	Translesion synthesis by POLK	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	1742,817	DLG4,CAMK2D
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	1742,817	DLG4,CAMK2D
R-HSA-1482925	Acyl chain remodelling of PG	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	81579,79888	PLA2G12A,LPCAT1
R-HSA-1482801	Acyl chain remodelling of PS	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	81579,10162	PLA2G12A,LPCAT3
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.183242606141843	-1.69694428750502	17	2	0.00529100529100529	378	8202	7187,329	TRAF3,BIRC2
R-HSA-198203	PI3K/AKT activation	0.183762547183349	-1.69411085922942	101	7	0.0185185185185185	378	8202	3667,57761,2254,2308,2247,2260,27327	IRS1,TRIB3,FGF9,FOXO1,FGF2,FGFR1,TNRC6A
R-HSA-1236394	Signaling by ERBB4	0.192043142525909	-1.65003523153999	312	18	0.0476190476190476	378	8202	2254,200734,4893,8831,2335,2308,2247,5786,5682,1742,2260,3667,817,57761,6464,7414,27327,6709	FGF9,SPRED2,NRAS,SYNGAP1,FN1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,TNRC6A,SPTAN1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.193181983989571	-1.64412261212341	33	3	0.00793650793650794	378	8202	5087,2247,2649	PBX1,FGF2,NR6A1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.193181983989571	-1.64412261212341	33	3	0.00793650793650794	378	8202	472,672,5890	ATM,BRCA1,RAD51B
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.193181983989571	-1.64412261212341	33	3	0.00793650793650794	378	8202	8871,8867,5305	SYNJ2,SYNJ1,PIP4K2A
R-HSA-163359	Glucagon signaling in metabolic regulation	0.193181983989571	-1.64412261212341	33	3	0.00793650793650794	378	8202	54331,2787,5567	GNG2,GNG5,PRKACB
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.194142516156645	-1.63916277025539	254	15	0.0396825396825397	378	8202	3667,2254,200734,817,4893,2335,6464,8831,2247,5786,5682,1742,7414,2260,6709	IRS1,FGF9,SPRED2,CAMK2D,NRAS,FN1,SHC1,SYNGAP1,FGF2,PTPRA,PSMA1,DLG4,VCL,FGFR1,SPTAN1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.19435950811219	-1.63804570025547	121	8	0.0211640211640212	378	8202	26052,8651,10010,7187,4793,329,5606,4208	DNM3,SOCS1,TANK,TRAF3,NFKBIB,BIRC2,MAP2K3,MEF2C
R-HSA-168898	Toll-Like Receptors Cascades	0.196778748600961	-1.62567528494597	140	9	0.0238095238095238	378	8202	26052,8651,10010,7187,4793,8411,329,5606,4208	DNM3,SOCS1,TANK,TRAF3,NFKBIB,EEA1,BIRC2,MAP2K3,MEF2C
R-HSA-2980766	Nuclear Envelope Breakdown	0.197637198353894	-1.62132226060651	50	4	0.0105820105820106	378	8202	5578,23279,9663,7112	PRKCA,NUP160,LPIN2,TMPO
R-HSA-112310	Neurotransmitter Release Cycle	0.197637198353894	-1.62132226060651	50	4	0.0105820105820106	378	8202	2744,6857,10550,54407	GLS,SYT1,ARL6IP5,SLC38A2
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.2002261962903	-1.60830757006031	18	2	0.00529100529100529	378	8202	7187,10010	TRAF3,TANK
R-HSA-69620	Cell Cycle Checkpoints	0.203104366789242	-1.59403530994135	179	11	0.0291005291005291	378	8202	8924,5984,9577,5983,55388,4174,8379,5682,472,672,7324	HERC2,RFC4,BRE,RFC3,MCM10,MCM5,MAD1L1,PSMA1,ATM,BRCA1,UBE2E1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.203382280958848	-1.59266791342563	68	5	0.0132275132275132	378	8202	8924,472,672,9577,7518	HERC2,ATM,BRCA1,BRE,XRCC4
R-HSA-2980736	Peptide hormone metabolism	0.20442382089315	-1.58755988686977	86	6	0.0158730158730159	378	8202	3800,1803,3798,6934,60412,148867	KIF5C,DPP4,KIF5A,TCF7L2,EXOC4,SLC30A7
R-HSA-381119	Unfolded Protein Response (UPR)	0.20442382089315	-1.58755988686977	86	6	0.0158730158730159	378	8202	7709,440,468,6464,5073,9709	ZBTB17,ASNS,ATF4,SHC1,PARN,HERPUD1
R-HSA-113418	Formation of the Early Elongation Complex	0.205165315213395	-1.58393920914705	34	3	0.00793650793650794	378	8202	2965,2967,6827	GTF2H1,GTF2H3,SUPT4H1
R-HSA-390522	Striated Muscle Contraction	0.205165315213395	-1.58393920914705	34	3	0.00793650793650794	378	8202	7134,7431,7273	TNNC1,VIM,TTN
R-HSA-4791275	Signaling by WNT in cancer	0.205165315213395	-1.58393920914705	34	3	0.00793650793650794	378	8202	54894,6934,22943	RNF43,TCF7L2,DKK1
R-HSA-5693537	Resolution of D-Loop Structures	0.205165315213395	-1.58393920914705	34	3	0.00793650793650794	378	8202	472,672,5890	ATM,BRCA1,RAD51B
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.205165315213395	-1.58393920914705	34	3	0.00793650793650794	378	8202	2965,2967,6827	GTF2H1,GTF2H3,SUPT4H1
R-HSA-1483255	PI Metabolism	0.207277320531792	-1.57369766961716	51	4	0.0105820105820106	378	8202	23760,8871,8867,5305	PITPNB,SYNJ2,SYNJ1,PIP4K2A
R-HSA-397795	G-protein beta:gamma signalling	0.207277320531792	-1.57369766961716	51	4	0.0105820105820106	378	8202	54331,6464,23236,2787	GNG2,SHC1,PLCB1,GNG5
R-HSA-1592230	Mitochondrial biogenesis	0.207277320531792	-1.57369766961716	51	4	0.0105820105820106	378	8202	80205,6907,133522,4208	CHD9,TBL1X,PPARGC1B,MEF2C
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.207277320531792	-1.57369766961716	51	4	0.0105820105820106	378	8202	2254,5578,2247,5567	FGF9,PRKCA,FGF2,PRKACB
R-HSA-75157	FasL/ CD95L signaling	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	843	CASP10
R-HSA-74713	IRS activation	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	3667	IRS1
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	5567	PRKACB
R-HSA-114516	Disinhibition of SNARE formation	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	5578	PRKCA
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	317	APAF1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	4121	MAN1A1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	317	APAF1
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	115677	NOSTRIN
R-HSA-1169092	Activation of RAS in B cells	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	4893	NRAS
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.210195156071741	-1.55971886518283	5	1	0.00264550264550265	378	8202	9942	XYLB
R-HSA-75153	Apoptotic execution  phase	0.21704997812973	-1.52762763799798	52	4	0.0105820105820106	378	8202	7431,3836,329,6709	VIM,KPNA1,BIRC2,SPTAN1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.217382639952553	-1.52609616050759	19	2	0.00529100529100529	378	8202	4893,6464	NRAS,SHC1
R-HSA-69618	Mitotic Spindle Checkpoint	0.217382639952553	-1.52609616050759	19	2	0.00529100529100529	378	8202	7324,8379	UBE2E1,MAD1L1
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.217382639952553	-1.52609616050759	19	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-110320	Translesion Synthesis by POLH	0.217382639952553	-1.52609616050759	19	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.217382639952553	-1.52609616050759	19	2	0.00529100529100529	378	8202	1742,817	DLG4,CAMK2D
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.217382639952553	-1.52609616050759	19	2	0.00529100529100529	378	8202	4893,6464	NRAS,SHC1
R-HSA-1643713	Signaling by EGFR in Cancer	0.217382639952553	-1.52609616050759	19	2	0.00529100529100529	378	8202	4893,6464	NRAS,SHC1
R-HSA-3858494	Beta-catenin independent WNT signaling	0.219328836734862	-1.51718313774392	144	9	0.0238095238095238	378	8202	54331,7976,5682,5578,23236,2787,5881,6934,27327	GNG2,FZD3,PSMA1,PRKCA,PLCB1,GNG5,RAC3,TCF7L2,TNRC6A
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.220051198590496	-1.51389503883918	70	5	0.0132275132275132	378	8202	3836,23279,9636,7324,2317	KPNA1,NUP160,ISG15,UBE2E1,FLNB
R-HSA-1169408	ISG15 antiviral mechanism	0.220051198590496	-1.51389503883918	70	5	0.0132275132275132	378	8202	3836,23279,9636,7324,2317	KPNA1,NUP160,ISG15,UBE2E1,FLNB
R-HSA-163685	Integration of energy metabolism	0.223055742321504	-1.50033357319092	107	7	0.0185185185185185	378	8202	54331,5578,23236,783,2787,5567,2770	GNG2,PRKCA,PLCB1,CACNB2,GNG5,PRKACB,GNAI1
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.225118809651643	-1.49112697324712	145	9	0.0238095238095238	378	8202	57459,2967,1107,25885,4774,2965,5451,64425,10302	GATAD2B,GTF2H3,CHD3,POLR1A,NFIA,GTF2H1,POU2F1,POLR1E,SNAPC5
R-HSA-1474228	Degradation of the extracellular matrix	0.226654001093301	-1.48433064857086	89	6	0.0158730158730159	378	8202	8754,4316,960,3911,4325,4323	ADAM9,MMP7,CD44,LAMA5,MMP16,MMP14
R-HSA-196854	Metabolism of vitamins and cofactors	0.234233689639739	-1.45143598829313	90	6	0.0158730158730159	378	8202	80308,6472,10243,3141,113278,5646	FLAD1,SHMT2,GPHN,HLCS,SLC52A3,PRSS3
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.234233689639739	-1.45143598829313	90	6	0.0158730158730159	378	8202	80308,6472,10243,3141,113278,5646	FLAD1,SHMT2,GPHN,HLCS,SLC52A3,PRSS3
R-HSA-190241	FGFR2 ligand binding and activation	0.23466010378687	-1.4496171787006	20	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-2028269	Signaling by Hippo	0.23466010378687	-1.4496171787006	20	2	0.00529100529100529	378	8202	23286,154810	WWC1,AMOTL1
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.23466010378687	-1.4496171787006	20	2	0.00529100529100529	378	8202	11343,5567	MGLL,PRKACB
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.23466010378687	-1.4496171787006	20	2	0.00529100529100529	378	8202	1803,6934	DPP4,TCF7L2
R-HSA-438064	Post NMDA receptor activation events	0.242023195775935	-1.41872170710502	37	3	0.00793650793650794	378	8202	1742,817,5567	DLG4,CAMK2D,PRKACB
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.242023195775935	-1.41872170710502	37	3	0.00793650793650794	378	8202	5984,5983,9636	RFC4,RFC3,ISG15
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	11343	MGLL
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	55253	TYW1
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	51	ACOX1
R-HSA-1482798	Acyl chain remodeling of CL	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	253558	LCLAT1
R-HSA-1566977	Fibronectin matrix formation	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	2335	FN1
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	472	ATM
R-HSA-947581	Molybdenum cofactor biosynthesis	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	10243	GPHN
R-HSA-211916	Vitamins	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	1591	CYP24A1
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	22943	DKK1
R-HSA-189483	Heme degradation	0.246616557925489	-1.39992054563379	6	1	0.00264550264550265	378	8202	3163	HMOX2
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.246726985772553	-1.39947287443055	168	10	0.0264550264550265	378	8202	3667,57761,2254,4893,2308,2247,5682,4793,2260,27327	IRS1,TRIB3,FGF9,NRAS,FOXO1,FGF2,PSMA1,NFKBIB,FGFR1,TNRC6A
R-HSA-5663205	Infectious disease	0.249222041115566	-1.38941104848584	347	19	0.0502645502645503	378	8202	2967,6872,8731,6924,5682,162,6857,23279,9636,5606,3304,51616,6827,3836,83860,79720,2965,7518,92421	GTF2H3,TAF1,RNMT,TCEB3,PSMA1,AP1B1,SYT1,NUP160,ISG15,MAP2K3,HSPA1B,TAF9B,SUPT4H1,KPNA1,TAF3,VPS37B,GTF2H1,XRCC4,CHMP4C
R-HSA-1474244	Extracellular matrix organization	0.249605678442918	-1.3878728925737	267	15	0.0396825396825397	378	8202	3910,667,4316,2335,2247,1462,3673,4323,8754,652,3691,5578,960,3911,4325	LAMA4,DST,MMP7,FN1,FGF2,VCAN,ITGA2,MMP14,ADAM9,BMP4,ITGB4,PRKCA,CD44,LAMA5,MMP16
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.252011141723131	-1.37828197926106	21	2	0.00529100529100529	378	8202	4893,5567	NRAS,PRKACB
R-HSA-445144	Signal transduction by L1	0.252011141723131	-1.37828197926106	21	2	0.00529100529100529	378	8202	8829,2260	NRP1,FGFR1
R-HSA-5620916	VxPx cargo-targeting to cilium	0.252011141723131	-1.37828197926106	21	2	0.00529100529100529	378	8202	50807,60412	ASAP1,EXOC4
R-HSA-5674135	MAP2K and MAPK activation	0.254547635379633	-1.36826728809107	38	3	0.00793650793650794	378	8202	4893,2335,7414	NRAS,FN1,VCL
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.254547635379633	-1.36826728809107	38	3	0.00793650793650794	378	8202	7431,329,6709	VIM,BIRC2,SPTAN1
R-HSA-1442490	Collagen degradation	0.254547635379633	-1.36826728809107	38	3	0.00793650793650794	378	8202	8754,4316,4323	ADAM9,MMP7,MMP14
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.254547635379633	-1.36826728809107	38	3	0.00793650793650794	378	8202	3836,23279,9636	KPNA1,NUP160,ISG15
R-HSA-1500931	Cell-Cell communication	0.256813035792009	-1.35940694602476	131	8	0.0211640211640212	378	8202	667,2318,5829,8935,84063,25945,3691,6709	DST,FLNC,PXN,SKAP2,KIRREL2,PVRL3,ITGB4,SPTAN1
R-HSA-3000178	ECM proteoglycans	0.257264171649279	-1.35765181676966	56	4	0.0105820105820106	378	8202	3910,3911,1462,3673	LAMA4,LAMA5,VCAN,ITGA2
R-HSA-166054	Activated TLR4 signalling	0.257838941048688	-1.35542014849282	112	7	0.0185185185185185	378	8202	7187,4793,8651,329,10010,5606,4208	TRAF3,NFKBIB,SOCS1,BIRC2,TANK,MAP2K3,MEF2C
R-HSA-416482	G alpha (12/13) signalling events	0.26337034199127	-1.33419409285653	75	5	0.0132275132275132	378	8202	54331,84033,23365,2787,7204	GNG2,OBSCN,ARHGEF12,GNG5,TRIO
R-HSA-977444	GABA B receptor activation	0.267160626978343	-1.3199052023003	39	3	0.00793650793650794	378	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-991365	Activation of GABAB receptors	0.267160626978343	-1.3199052023003	39	3	0.00793650793650794	378	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-373753	Nephrin interactions	0.269392402390412	-1.31158621736936	22	2	0.00529100529100529	378	8202	84063,6709	KIRREL2,SPTAN1
R-HSA-3371571	HSF1-dependent transactivation	0.269392402390412	-1.31158621736936	22	2	0.00529100529100529	378	8202	817,3304	CAMK2D,HSPA1B
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.269392402390412	-1.31158621736936	22	2	0.00529100529100529	378	8202	2247,2649	FGF2,NR6A1
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.27984465333352	-1.27352063929978	40	3	0.00793650793650794	378	8202	5451,10302,4774	POU2F1,SNAPC5,NFIA
R-HSA-168253	Host Interactions with Influenza Factors	0.27984465333352	-1.27352063929978	40	3	0.00793650793650794	378	8202	3836,23279,9636	KPNA1,NUP160,ISG15
R-HSA-74158	RNA Polymerase III Transcription	0.27984465333352	-1.27352063929978	40	3	0.00793650793650794	378	8202	5451,10302,4774	POU2F1,SNAPC5,NFIA
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.281196965378933	-1.26869991078617	96	6	0.0158730158730159	378	8202	9497,6541,6520,23657,81539,54407	SLC4A7,SLC7A1,SLC3A2,SLC7A11,SLC38A1,SLC38A2
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.281226786919589	-1.26859386426676	77	5	0.0132275132275132	378	8202	2965,2967,5984,5983,27339	GTF2H1,GTF2H3,RFC4,RFC3,PRPF19
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	5567	PRKACB
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	7112	TMPO
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	148867	SLC30A7
R-HSA-447038	NrCAM interactions	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	1742	DLG4
R-HSA-111471	Apoptotic factor-mediated response	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	317	APAF1
R-HSA-75158	TRAIL  signaling	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	843	CASP10
R-HSA-196791	Vitamin D (calciferol) metabolism	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	1591	CYP24A1
R-HSA-3595177	Defective CHSY1 causes TPBS	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-190371	FGFR3b ligand binding and activation	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	2254	FGF9
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	25945	PVRL3
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	5226	PGD
R-HSA-164843	2-LTR circle formation	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	7518	XRCC4
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	27327	TNRC6A
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.281362646401246	-1.26811088511268	7	1	0.00264550264550265	378	8202	6934	TCF7L2
R-HSA-5693538	Homology Directed Repair	0.283390741967434	-1.26092861998169	135	8	0.0211640211640212	378	8202	8924,5984,9577,5983,10038,5890,472,672	HERC2,RFC4,BRE,RFC3,PARP2,RAD51B,ATM,BRCA1
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.28676435420732	-1.24909446596112	23	2	0.00529100529100529	378	8202	1803,6934	DPP4,TCF7L2
R-HSA-1482839	Acyl chain remodelling of PE	0.28676435420732	-1.24909446596112	23	2	0.00529100529100529	378	8202	81579,10162	PLA2G12A,LPCAT3
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.28676435420732	-1.24909446596112	23	2	0.00529100529100529	378	8202	4088,6498	SMAD3,SKIL
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.28676435420732	-1.24909446596112	23	2	0.00529100529100529	378	8202	5984,5983	RFC4,RFC3
R-HSA-428930	Thromboxane signalling through TP receptor	0.28676435420732	-1.24909446596112	23	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.28676435420732	-1.24909446596112	23	2	0.00529100529100529	378	8202	2678,1800	GGT1,DPEP1
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.289231719407082	-1.24052711488107	97	6	0.0158730158730159	378	8202	7187,4793,329,10010,5606,4208	TRAF3,NFKBIB,BIRC2,TANK,MAP2K3,MEF2C
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.289231719407082	-1.24052711488107	97	6	0.0158730158730159	378	8202	7187,4793,329,10010,5606,4208	TRAF3,NFKBIB,BIRC2,TANK,MAP2K3,MEF2C
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.289231719407082	-1.24052711488107	97	6	0.0158730158730159	378	8202	7187,4793,329,10010,5606,4208	TRAF3,NFKBIB,BIRC2,TANK,MAP2K3,MEF2C
R-HSA-5693607	Processing of DNA double-strand break ends	0.289231719407082	-1.24052711488107	97	6	0.0158730158730159	378	8202	8924,472,5984,672,9577,5983	HERC2,ATM,RFC4,BRCA1,BRE,RFC3
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.292582825507642	-1.22900748826493	41	3	0.00793650793650794	378	8202	1742,817,5567	DLG4,CAMK2D,PRKACB
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.304091026836083	-1.19042819201439	24	2	0.00529100529100529	378	8202	7187,4793	TRAF3,NFKBIB
R-HSA-5260271	Diseases of Immune System	0.304091026836083	-1.19042819201439	24	2	0.00529100529100529	378	8202	7187,4793	TRAF3,NFKBIB
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.305020196792095	-1.18737728557663	198	11	0.0291005291005291	378	8202	3667,57761,2254,4893,6464,2308,2247,5682,4793,2260,27327	IRS1,TRIB3,FGF9,NRAS,SHC1,FOXO1,FGF2,PSMA1,NFKBIB,FGFR1,TNRC6A
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.305358898546135	-1.18626747761829	42	3	0.00793650793650794	378	8202	54331,2787,5567	GNG2,GNG5,PRKACB
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.30932174115866	-1.17337331026885	61	4	0.0105820105820106	378	8202	3667,2254,2247,2260	IRS1,FGF9,FGF2,FGFR1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.313235514675182	-1.16079992833363	342	18	0.0476190476190476	378	8202	2254,200734,4893,2335,8831,2308,2247,5786,5682,1742,2260,3667,817,57761,6464,7414,6709,27327	FGF9,SPRED2,NRAS,FN1,SYNGAP1,FOXO1,FGF2,PTPRA,PSMA1,DLG4,FGFR1,IRS1,CAMK2D,TRIB3,SHC1,VCL,SPTAN1,TNRC6A
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	54894	RNF43
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	5366	PMAIP1
R-HSA-1483115	Hydrolysis of LPC	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	56261	GPCPD1
R-HSA-400451	Free fatty acids regulate insulin secretion	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	23236	PLCB1
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	5578	PRKCA
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	23236	PLCB1
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	57761	TRIB3
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	4793	NFKBIB
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	89978	DPH6
R-HSA-72731	Recycling of eIF2:GDP	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	8891	EIF2B3
R-HSA-2046105	Linoleic acid (LA) metabolism	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	3992	FADS1
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	5829	PXN
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.31451028760095	-1.15673849240382	8	1	0.00264550264550265	378	8202	57142	RTN4
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.318157282748153	-1.14520941863918	43	3	0.00793650793650794	378	8202	4088,6498,4092	SMAD3,SKIL,SMAD7
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.318157282748153	-1.14520941863918	43	3	0.00793650793650794	378	8202	54331,2787,5567	GNG2,GNG5,PRKACB
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.321339768412296	-1.13525624706088	25	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-1296059	G protein gated Potassium channels	0.321339768412296	-1.13525624706088	25	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-162588	Budding and maturation of HIV virion	0.321339768412296	-1.13525624706088	25	2	0.00529100529100529	378	8202	79720,92421	VPS37B,CHMP4C
R-HSA-982772	Growth hormone receptor signaling	0.321339768412296	-1.13525624706088	25	2	0.00529100529100529	378	8202	3667,8651	IRS1,SOCS1
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.321339768412296	-1.13525624706088	25	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-1296041	Activation of G protein gated Potassium channels	0.321339768412296	-1.13525624706088	25	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.321806686341762	-1.13380426669763	101	6	0.0158730158730159	378	8202	6566,23516,30061,861,7922,148867	SLC16A1,SLC39A14,SLC40A1,RUNX1,SLC39A7,SLC30A7
R-HSA-5693532	DNA Double-Strand Break Repair	0.330775501537028	-1.10631537680652	162	9	0.0238095238095238	378	8202	8924,5984,9577,5983,10038,5890,472,672,7518	HERC2,RFC4,BRE,RFC3,PARP2,RAD51B,ATM,BRCA1,XRCC4
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.330963050941369	-1.10574853841193	44	3	0.00793650793650794	378	8202	2965,2967,10038	GTF2H1,GTF2H3,PARP2
R-HSA-382556	ABC-family proteins mediated transport	0.330963050941369	-1.10574853841193	44	3	0.00793650793650794	378	8202	8714,1244,10347	ABCC3,ABCC2,ABCA7
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.331436684878268	-1.10431848344058	142	8	0.0211640211640212	378	8202	54331,817,1742,5578,23236,2787,5567,2770	GNG2,CAMK2D,DLG4,PRKCA,PLCB1,GNG5,PRKACB,GNAI1
R-HSA-425407	SLC-mediated transmembrane transport	0.332449515609714	-1.10126726316673	264	14	0.037037037037037	378	8202	23516,6541,30061,6520,23657,81539,7922,54407,3099,6566,9497,861,23279,148867	SLC39A14,SLC7A1,SLC40A1,SLC3A2,SLC7A11,SLC38A1,SLC39A7,SLC38A2,HK2,SLC16A1,SLC4A7,RUNX1,NUP160,SLC30A7
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.335974680227577	-1.09071947832392	83	5	0.0132275132275132	378	8202	2965,2967,5984,5983,10038	GTF2H1,GTF2H3,RFC4,RFC3,PARP2
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.338481017365422	-1.0832872668864	26	2	0.00529100529100529	378	8202	51384,79971	WNT16,WLS
R-HSA-193648	NRAGE signals death through JNK	0.343761942274386	-1.06780588944297	45	3	0.00793650793650794	378	8202	84033,23365,7204	OBSCN,ARHGEF12,TRIO
R-HSA-422475	Axon guidance	0.345507624507802	-1.06274056797796	516	26	0.0687830687830688	378	8202	1948,2254,200734,26052,51466,4893,8831,2335,2247,287,5786,7204,5682,1742,55740,23365,2260,3667,817,6464,783,3673,5962,8829,7414,6709	EFNB2,FGF9,SPRED2,DNM3,EVL,NRAS,SYNGAP1,FN1,FGF2,ANK2,PTPRA,TRIO,PSMA1,DLG4,ENAH,ARHGEF12,FGFR1,IRS1,CAMK2D,SHC1,CACNB2,ITGA2,RDX,NRP1,VCL,SPTAN1
R-HSA-425381	Bicarbonate transporters	0.346132829860151	-1.06093267626576	9	1	0.00264550264550265	378	8202	9497	SLC4A7
R-HSA-73614	Pyrimidine salvage reactions	0.346132829860151	-1.06093267626576	9	1	0.00264550264550265	378	8202	7378	UPP1
R-HSA-112411	MAPK1 (ERK2) activation	0.346132829860151	-1.06093267626576	9	1	0.00264550264550265	378	8202	3570	IL6R
R-HSA-193697	p75NTR regulates axonogenesis	0.346132829860151	-1.06093267626576	9	1	0.00264550264550265	378	8202	57142	RTN4
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.346132829860151	-1.06093267626576	9	1	0.00264550264550265	378	8202	2308	FOXO1
R-HSA-1462054	Alpha-defensins	0.346132829860151	-1.06093267626576	9	1	0.00264550264550265	378	8202	5646	PRSS3
R-HSA-427413	NoRC negatively regulates rRNA expression	0.34657762497703	-1.0596484595345	104	6	0.0158730158730159	378	8202	2965,2967,29115,64425,25885,8819	GTF2H1,GTF2H3,SAP30BP,POLR1E,POLR1A,SAP30
R-HSA-1280215	Cytokine Signaling in Immune system	0.353087338285944	-1.0410398354108	539	27	0.0714285714285714	378	8202	2254,200734,4893,2335,8831,3460,2247,5786,5682,1742,3570,23279,329,9636,2260,7324,2317,3667,817,3836,6464,8651,7187,960,10581,7414,6709	FGF9,SPRED2,NRAS,FN1,SYNGAP1,IFNGR2,FGF2,PTPRA,PSMA1,DLG4,IL6R,NUP160,BIRC2,ISG15,FGFR1,UBE2E1,FLNB,IRS1,CAMK2D,KPNA1,SHC1,SOCS1,TRAF3,CD44,IFITM2,VCL,SPTAN1
R-HSA-69242	S Phase	0.354030653411779	-1.0383717780385	125	7	0.0185185185185185	378	8202	5682,5984,114799,5983,328,4174,1019	PSMA1,RFC4,ESCO1,RFC3,APEX1,MCM5,CDK4
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.354459982220768	-1.03715982451379	85	5	0.0132275132275132	378	8202	3667,2254,2308,2247,2260	IRS1,FGF9,FOXO1,FGF2,FGFR1
R-HSA-112316	Neuronal System	0.354660275271541	-1.03659491876195	289	15	0.0396825396825397	378	8202	2744,54331,817,81539,10550,783,54407,1742,23416,5578,6857,23236,2787,5567,2770	GLS,GNG2,CAMK2D,SLC38A1,ARL6IP5,CACNB2,SLC38A2,DLG4,KCNH3,PRKCA,SYT1,PLCB1,GNG5,PRKACB,GNAI1
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.355488088244941	-1.0342635373468	27	2	0.00529100529100529	378	8202	2335,6464	FN1,SHC1
R-HSA-180024	DARPP-32 events	0.355488088244941	-1.0342635373468	27	2	0.00529100529100529	378	8202	5567,5142	PRKACB,PDE4B
R-HSA-437239	Recycling pathway of L1	0.355488088244941	-1.0342635373468	27	2	0.00529100529100529	378	8202	5962,26052	RDX,DNM3
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.355488088244941	-1.0342635373468	27	2	0.00529100529100529	378	8202	23236,8867	PLCB1,SYNJ1
R-HSA-449147	Signaling by Interleukins	0.360841251900909	-1.01931716279248	311	16	0.0423280423280423	378	8202	2254,200734,4893,2335,8831,2247,5786,5682,1742,3570,2260,3667,817,6464,7414,6709	FGF9,SPRED2,NRAS,FN1,SYNGAP1,FGF2,PTPRA,PSMA1,DLG4,IL6R,FGFR1,IRS1,CAMK2D,SHC1,VCL,SPTAN1
R-HSA-69306	DNA Replication	0.36319149938435	-1.01282503730767	106	6	0.0158730158730159	378	8202	5682,5984,5983,55388,328,4174	PSMA1,RFC4,RFC3,MCM10,APEX1,MCM5
R-HSA-446728	Cell junction organization	0.3637214736613	-1.01136688649593	86	5	0.0132275132275132	378	8202	667,2318,5829,3691,25945	DST,FLNC,PXN,ITGB4,PVRL3
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.371516395845981	-0.990162281623291	107	6	0.0158730158730159	378	8202	2965,2967,29115,64425,25885,8819	GTF2H1,GTF2H3,SAP30BP,POLR1E,POLR1A,SAP30
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.371516395845981	-0.990162281623291	107	6	0.0158730158730159	378	8202	2965,57459,2967,1107,64425,25885	GTF2H1,GATAD2B,GTF2H3,CHD3,POLR1E,POLR1A
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.372336970563369	-0.98795599988202	28	2	0.00529100529100529	378	8202	5451,10302	POU2F1,SNAPC5
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.372336970563369	-0.98795599988202	28	2	0.00529100529100529	378	8202	79720,92421	VPS37B,CHMP4C
R-HSA-111933	Calmodulin induced events	0.372336970563369	-0.98795599988202	28	2	0.00529100529100529	378	8202	5578,5567	PRKCA,PRKACB
R-HSA-111997	CaM pathway	0.372336970563369	-0.98795599988202	28	2	0.00529100529100529	378	8202	5578,5567	PRKCA,PRKACB
R-HSA-5658442	Regulation of RAS by GAPs	0.372893651579963	-0.986462016399338	67	4	0.0105820105820106	378	8202	5682,200734,4893,8831	PSMA1,SPRED2,NRAS,SYNGAP1
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.372988336811851	-0.986208128428129	87	5	0.0132275132275132	378	8202	5682,677,5578,5073,3304	PSMA1,ZFP36L1,PRKCA,PARN,HSPA1B
R-HSA-168799	Neurotoxicity of clostridium toxins	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-381183	ATF6-alpha activates chaperone genes	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	468	ATF4
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	4595	MUTYH
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	10038	PARP2
R-HSA-2474795	Diseases associated with visual transduction	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	5947	RBP1
R-HSA-549127	Organic cation transport	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	861	RUNX1
R-HSA-110056	MAPK3 (ERK1) activation	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	3570	IL6R
R-HSA-2453864	Retinoid cycle disease events	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	5947	RBP1
R-HSA-190377	FGFR2b ligand binding and activation	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	2247	FGF2
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.37630026429146	-0.977367879040552	10	1	0.00264550264550265	378	8202	162	AP1B1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.381984733222999	-0.962374636559017	48	3	0.00793650793650794	378	8202	54331,6464,2787	GNG2,SHC1,GNG5
R-HSA-5687128	MAPK6/MAPK4 signaling	0.382255323782528	-0.961666506781323	88	5	0.0132275132275132	378	8202	5682,10435,2308,5567,27327	PSMA1,CDC42EP2,FOXO1,PRKACB,TNRC6A
R-HSA-71387	Metabolism of carbohydrates	0.384288633016655	-0.956361360259782	274	14	0.037037037037037	378	8202	9942,3038,57214,1462,3099,3373,8604,960,23279,5631,5567,6576,9653,5226	XYLB,HAS3,CEMIP,VCAN,HK2,HYAL1,SLC25A12,CD44,NUP160,PRPS1,PRKACB,SLC25A1,HS2ST1,PGD
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.38450982852925	-0.955785928518532	129	7	0.0185185185185185	378	8202	8924,472,5984,672,9577,5983,5890	HERC2,ATM,RFC4,BRCA1,BRE,RFC3,RAD51B
R-HSA-5696398	Nucleotide Excision Repair	0.388182657457272	-0.94627928349226	109	6	0.0158730158730159	378	8202	2965,2967,5984,5983,10038,27339	GTF2H1,GTF2H3,RFC4,RFC3,PARP2,PRPF19
R-HSA-73864	RNA Polymerase I Transcription	0.388182657457272	-0.94627928349226	109	6	0.0158730158730159	378	8202	2965,57459,2967,1107,64425,25885	GTF2H1,GATAD2B,GTF2H3,CHD3,POLR1E,POLR1A
R-HSA-375170	CDO in myogenesis	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	6938,4208	TCF12,MEF2C
R-HSA-445355	Smooth Muscle Contraction	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	5829,7414	PXN,VCL
R-HSA-5339562	Uptake and actions of bacterial toxins	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	6857,5606	SYT1,MAP2K3
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-445095	Interaction between L1 and Ankyrins	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	287,6709	ANK2,SPTAN1
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	3836,23279	KPNA1,NUP160
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	9588,475	PRDX6,ATOX1
R-HSA-525793	Myogenesis	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	6938,4208	TCF12,MEF2C
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.389006140021721	-0.944160151370724	29	2	0.00529100529100529	378	8202	1742,817	DLG4,CAMK2D
R-HSA-913531	Interferon Signaling	0.404397387932116	-0.905357250976077	194	10	0.0264550264550265	378	8202	817,3836,8651,3460,960,10581,23279,9636,2317,7324	CAMK2D,KPNA1,SOCS1,IFNGR2,CD44,IFITM2,NUP160,ISG15,FLNB,UBE2E1
R-HSA-69473	G2/M DNA damage checkpoint	0.404608038578359	-0.90483648648155	70	4	0.0105820105820106	378	8202	8924,472,672,9577	HERC2,ATM,BRCA1,BRE
R-HSA-2022923	Dermatan sulfate biosynthesis	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-5625970	RHO GTPases activate KTN1	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	3798	KIF5A
R-HSA-196780	Biotin transport and metabolism	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	3141	HLCS
R-HSA-1980148	Signaling by NOTCH3	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-196757	Metabolism of folate and pterines	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	6472	SHMT2
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	114799	ESCO1
R-HSA-1059683	Interleukin-6 signaling	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	3570	IL6R
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	79720	VPS37B
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	788	SLC25A20
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	79720	VPS37B
R-HSA-5655291	Signaling by FGFR4 in disease	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	4893	NRAS
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	8867	SYNJ1
R-HSA-1980150	Signaling by NOTCH4	0.405079378072848	-0.903672235838555	11	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-111996	Ca-dependent events	0.405476381376708	-0.902692652803144	30	2	0.00529100529100529	378	8202	5578,5567	PRKCA,PRKACB
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.405476381376708	-0.902692652803144	30	2	0.00529100529100529	378	8202	6827,6924	SUPT4H1,TCEB3
R-HSA-420092	Glucagon-type ligand receptors	0.405476381376708	-0.902692652803144	30	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-68962	Activation of the pre-replicative complex	0.405476381376708	-0.902692652803144	30	2	0.00529100529100529	378	8202	55388,4174	MCM10,MCM5
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.405476381376708	-0.902692652803144	30	2	0.00529100529100529	378	8202	6827,6924	SUPT4H1,TCEB3
R-HSA-191859	snRNP Assembly	0.407200601066611	-0.898449337650127	50	3	0.00793650793650794	378	8202	25929,23279,1207	GEMIN5,NUP160,CLNS1A
R-HSA-194441	Metabolism of non-coding RNA	0.407200601066611	-0.898449337650127	50	3	0.00793650793650794	378	8202	25929,23279,1207	GEMIN5,NUP160,CLNS1A
R-HSA-383280	Nuclear Receptor transcription pathway	0.419695806094755	-0.868225101318788	51	3	0.00793650793650794	378	8202	5468,2649,7025	PPARG,NR6A1,NR2F1
R-HSA-445717	Aquaporin-mediated transport	0.419695806094755	-0.868225101318788	51	3	0.00793650793650794	378	8202	54331,2787,5567	GNG2,GNG5,PRKACB
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.419695806094755	-0.868225101318788	51	3	0.00793650793650794	378	8202	50807,200894,60412	ASAP1,ARL13B,EXOC4
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.421730622301406	-0.863388504547811	31	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-167287	HIV elongation arrest and recovery	0.421730622301406	-0.863388504547811	31	2	0.00529100529100529	378	8202	6827,6924	SUPT4H1,TCEB3
R-HSA-1296065	Inwardly rectifying K+ channels	0.421730622301406	-0.863388504547811	31	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-167290	Pausing and recovery of HIV elongation	0.421730622301406	-0.863388504547811	31	2	0.00529100529100529	378	8202	6827,6924	SUPT4H1,TCEB3
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.421730622301406	-0.863388504547811	31	2	0.00529100529100529	378	8202	4088,4092	SMAD3,SMAD7
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.421730622301406	-0.863388504547811	31	2	0.00529100529100529	378	8202	23279,3304	NUP160,HSPA1B
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.421730622301406	-0.863388504547811	31	2	0.00529100529100529	378	8202	3836,23279	KPNA1,NUP160
R-HSA-1268020	Mitochondrial protein import	0.432102693517983	-0.8390920025113	52	3	0.00793650793650794	378	8202	8604,10469,617	SLC25A12,TIMM44,BCS1L
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	843	CASP10
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	1742	DLG4
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	1742	DLG4
R-HSA-390666	Serotonin receptors	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	3363	HTR7
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	328	APEX1
R-HSA-176974	Unwinding of DNA	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	4174	MCM5
R-HSA-211979	Eicosanoids	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	6916	TBXAS1
R-HSA-381033	ATF6-alpha activates chaperones	0.432533900733588	-0.838094572482958	12	1	0.00264550264550265	378	8202	468	ATF4
R-HSA-1280218	Adaptive Immune System	0.435870614119316	-0.83040983628113	668	32	0.0846560846560847	378	8202	8924,26052,2308,9871,3798,55740,162,10666,55824,6464,8651,51164,26046,79659,90678,5567,2254,4893,51466,2247,5682,3093,7324,2260,1525,114876,1778,3667,57761,57630,4793,27327	HERC2,DNM3,FOXO1,SEC24D,KIF5A,ENAH,AP1B1,CD226,PAG1,SHC1,SOCS1,DCTN4,LTN1,DYNC2H1,LRSAM1,PRKACB,FGF9,NRAS,EVL,FGF2,PSMA1,UBE2K,UBE2E1,FGFR1,CXADR,OSBPL1A,DYNC1H1,IRS1,TRIB3,SH3RF1,NFKBIB,TNRC6A
R-HSA-3214815	HDACs deacetylate histones	0.437581651001603	-0.826491959737034	94	5	0.0132275132275132	378	8202	57459,6907,1107,317772,8819	GATAD2B,TBL1X,CHD3,HIST2H2AB,SAP30
R-HSA-202433	Generation of second messenger molecules	0.437753777559535	-0.826098678362754	32	2	0.00529100529100529	378	8202	55740,51466	ENAH,EVL
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.437753777559535	-0.826098678362754	32	2	0.00529100529100529	378	8202	54331,2787	GNG2,GNG5
R-HSA-376176	Signaling by Robo receptor	0.437753777559535	-0.826098678362754	32	2	0.00529100529100529	378	8202	55740,51466	ENAH,EVL
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.446382943769118	-0.806578077047509	74	4	0.0105820105820106	378	8202	8924,472,672,9577	HERC2,ATM,BRCA1,BRE
R-HSA-5694530	Cargo concentration in the ER	0.453532602954638	-0.790688120159579	33	2	0.00529100529100529	378	8202	149111,9871	CNIH3,SEC24D
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.456615666018303	-0.783913235316672	54	3	0.00793650793650794	378	8202	667,4316,3691	DST,MMP7,ITGB4
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.456615666018303	-0.783913235316672	54	3	0.00793650793650794	378	8202	2965,2967,27339	GTF2H1,GTF2H3,PRPF19
R-HSA-5693606	DNA Double Strand Break Response	0.456693512889046	-0.783742763207709	75	4	0.0105820105820106	378	8202	8924,472,672,9577	HERC2,ATM,BRCA1,BRE
R-HSA-1502540	Signaling by Activin	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	4088	SMAD3
R-HSA-211227	Activation of DNA fragmentation factor	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	3836	KPNA1
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	1803	DPP4
R-HSA-174403	Glutathione synthesis and recycling	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	2678	GGT1
R-HSA-5210891	Uptake and function of anthrax toxins	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	5606	MAP2K3
R-HSA-171007	p38MAPK events	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	4893	NRAS
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	783	CACNB2
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	7112	TMPO
R-HSA-140342	Apoptosis induced DNA fragmentation	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	3836	KPNA1
R-HSA-2995410	Nuclear Envelope Reassembly	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	7112	TMPO
R-HSA-5626467	RHO GTPases activate IQGAPs	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	10788	IQGAP2
R-HSA-4641265	Repression of WNT target genes	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	6934	TCF7L2
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	8935	SKAP2
R-HSA-75892	Platelet Adhesion to exposed collagen	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	3673	ITGA2
R-HSA-1483213	Synthesis of PE	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	9663	LPIN2
R-HSA-177504	Retrograde neurotrophin signalling	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	26052	DNM3
R-HSA-1663150	The activation of arylsulfatases	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	79642	ARSJ
R-HSA-175474	Assembly Of The HIV Virion	0.458724643782032	-0.779305153550672	13	1	0.00264550264550265	378	8202	79720	VPS37B
R-HSA-2142753	Arachidonic acid metabolism	0.468705294236584	-0.757781078541031	55	3	0.00793650793650794	378	8202	2678,1800,6916	GGT1,DPEP1,TBXAS1
R-HSA-977443	GABA receptor activation	0.468705294236584	-0.757781078541031	55	3	0.00793650793650794	378	8202	54331,2787,2770	GNG2,GNG5,GNAI1
R-HSA-6784531	tRNA processing in the nucleus	0.468705294236584	-0.757781078541031	55	3	0.00793650793650794	378	8202	10940,80746,23279	POP1,TSEN2,NUP160
R-HSA-1489509	DAG and IP3 signaling	0.469055558440236	-0.757034056058826	34	2	0.00529100529100529	378	8202	5578,5567	PRKCA,PRKACB
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.469055558440236	-0.757034056058826	34	2	0.00529100529100529	378	8202	2254,2247	FGF9,FGF2
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.469055558440236	-0.757034056058826	34	2	0.00529100529100529	378	8202	3836,23279	KPNA1,NUP160
R-HSA-69239	Synthesis of DNA	0.473868352614612	-0.746825732963127	98	5	0.0132275132275132	378	8202	5682,5984,5983,328,4174	PSMA1,RFC4,RFC3,APEX1,MCM5
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.477115467491063	-0.73999674717619	77	4	0.0105820105820106	378	8202	54386,472,8091,57634	TERF2IP,ATM,HMGA2,EP400
R-HSA-70326	Glucose metabolism	0.477115467491063	-0.73999674717619	77	4	0.0105820105820106	378	8202	8604,5567,6576,3099	SLC25A12,PRKACB,SLC25A1,HK2
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	6916	TBXAS1
R-HSA-3371568	Attenuation phase	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	3304	HSPA1B
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	2770	GNAI1
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	8829	NRP1
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	2770	GNAI1
R-HSA-418885	DCC mediated attractive signaling	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	7204	TRIO
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	7187	TRAF3
R-HSA-5682910	LGI-ADAM interactions	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	1742	DLG4
R-HSA-5675482	Regulation of necroptotic cell death	0.483709633957518	-0.726270482135257	14	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.484312679919817	-0.725024547962738	35	2	0.00529100529100529	378	8202	5451,10302	POU2F1,SNAPC5
R-HSA-157579	Telomere Maintenance	0.487216644465038	-0.719046399653921	78	4	0.0105820105820106	378	8202	54386,5984,5983,328	TERF2IP,RFC4,RFC3,APEX1
R-HSA-167021	PLC-gamma1 signalling	0.499295459131342	-0.694557255986501	36	2	0.00529100529100529	378	8202	5578,5567	PRKCA,PRKACB
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.499295459131342	-0.694557255986501	36	2	0.00529100529100529	378	8202	89978,79642	DPH6,ARSJ
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.499295459131342	-0.694557255986501	36	2	0.00529100529100529	378	8202	5578,5567	PRKCA,PRKACB
R-HSA-1630316	Glycosaminoglycan metabolism	0.503208449801004	-0.686750781604531	123	6	0.0158730158730159	378	8202	3373,960,3038,57214,1462,9653	HYAL1,CD44,HAS3,CEMIP,VCAN,HS2ST1
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	2335	FN1
R-HSA-159418	Recycling of bile acids and salts	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	8714	ABCC3
R-HSA-549132	Organic cation/anion/zwitterion transport	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	861	RUNX1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	2335	FN1
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	22943	DKK1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.507544240506834	-0.678171398453095	15	1	0.00264550264550265	378	8202	5578	PRKCA
R-HSA-212165	Epigenetic regulation of gene expression	0.511179501217472	-0.671034476062656	124	6	0.0158730158730159	378	8202	2965,2967,29115,64425,25885,8819	GTF2H1,GTF2H3,SAP30BP,POLR1E,POLR1A,SAP30
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.513996731330023	-0.665538372827303	37	2	0.00529100529100529	378	8202	2335,6464	FN1,SHC1
R-HSA-156590	Glutathione conjugation	0.513996731330023	-0.665538372827303	37	2	0.00529100529100529	378	8202	2678,4257	GGT1,MGST1
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.513996731330023	-0.665538372827303	37	2	0.00529100529100529	378	8202	5578,5567	PRKCA,PRKACB
R-HSA-193704	p75 NTR receptor-mediated signalling	0.526782200917032	-0.640968096857251	82	4	0.0105820105820106	378	8202	84033,57142,23365,7204	OBSCN,RTN4,ARHGEF12,TRIO
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.528410569992736	-0.637881702762775	38	2	0.00529100529100529	378	8202	317,5366	APAF1,PMAIP1
R-HSA-69236	G1 Phase	0.528410569992736	-0.637881702762775	38	2	0.00529100529100529	378	8202	1021,1019	CDK6,CDK4
R-HSA-69231	Cyclin D associated events in G1	0.528410569992736	-0.637881702762775	38	2	0.00529100529100529	378	8202	1021,1019	CDK6,CDK4
R-HSA-1482922	Acyl chain remodelling of PI	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	81579	PLA2G12A
R-HSA-399956	CRMPs in Sema3A signaling	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	8829	NRP1
R-HSA-5218859	Regulated Necrosis	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-392517	Rap1 signalling	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	5567	PRKACB
R-HSA-163615	PKA activation	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	5567	PRKACB
R-HSA-5625900	RHO GTPases activate CIT	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	1742	DLG4
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	7048	TGFBR2
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	8829	NRP1
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	5578	PRKCA
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-69183	Processive synthesis on the lagging strand	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	328	APEX1
R-HSA-1369062	ABC transporters in lipid homeostasis	0.530281296458873	-0.634347665197283	16	1	0.00264550264550265	378	8202	10347	ABCA7
R-HSA-382551	Transmembrane transport of small molecules	0.530732232861555	-0.63349765449078	586	27	0.0714285714285714	378	8202	30061,6520,81539,535,6262,1244,3163,10110,28982,23279,51076,10347,148867,54331,23516,6541,23657,7922,54407,3099,6566,9497,8714,57719,861,2787,5567	SLC40A1,SLC3A2,SLC38A1,ATP6V0A1,RYR2,ABCC2,HMOX2,SGK2,FLVCR1,NUP160,CUTC,ABCA7,SLC30A7,GNG2,SLC39A14,SLC7A1,SLC7A11,SLC39A7,SLC38A2,HK2,SLC16A1,SLC4A7,ABCC3,ANO8,RUNX1,GNG5,PRKACB
R-HSA-73886	Chromosome Maintenance	0.535360919574841	-0.624814143509493	105	5	0.0132275132275132	378	8202	54386,5984,5983,328,401541	TERF2IP,RFC4,RFC3,APEX1,CENPP
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.538475514572195	-0.619013253108988	61	3	0.00793650793650794	378	8202	84033,23365,7204	OBSCN,ARHGEF12,TRIO
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	7324	UBE2E1
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	5567	PRKACB
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	5606	MAP2K3
R-HSA-176412	Phosphorylation of the APC/C	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	7324	UBE2E1
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	677	ZFP36L1
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	5073	PARN
R-HSA-164378	PKA activation in glucagon signalling	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	5567	PRKACB
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.551971214613411	-0.59425938150424	17	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.560547217716978	-0.578841797882538	63	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.560547217716978	-0.578841797882538	63	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-3371556	Cellular response to heat stress	0.564817359501122	-0.571252857614809	86	4	0.0105820105820106	378	8202	472,817,23279,3304	ATM,CAMK2D,NUP160,HSPA1B
R-HSA-5620924	Intraflagellar transport	0.569884772515821	-0.562321092070326	41	2	0.00529100529100529	378	8202	79659,57539	DYNC2H1,WDR35
R-HSA-70153	Glucose transport	0.569884772515821	-0.562321092070326	41	2	0.00529100529100529	378	8202	23279,3099	NUP160,HK2
R-HSA-3214841	PKMTs methylate histone lysines	0.571341619389021	-0.559767965583066	64	3	0.00793650793650794	378	8202	58508,55904,79813	KMT2C,KMT2E,EHMT1
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.572662098029899	-0.557459442966916	18	1	0.00264550264550265	378	8202	1523	CUX1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.572662098029899	-0.557459442966916	18	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.572662098029899	-0.557459442966916	18	1	0.00264550264550265	378	8202	7324	UBE2E1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.572662098029899	-0.557459442966916	18	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-156584	Cytosolic sulfonation of small molecules	0.572662098029899	-0.557459442966916	18	1	0.00264550264550265	378	8202	6819	SULT1C2
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.572662098029899	-0.557459442966916	18	1	0.00264550264550265	378	8202	7324	UBE2E1
R-HSA-194315	Signaling by Rho GTPases	0.573419705357456	-0.556137360309868	399	18	0.0476190476190476	378	8202	23092,51466,3798,7204,1742,84033,23365,100288637,23279,5881,401541,10788,58480,93663,8379,101928168,114793,23081	ARHGAP26,EVL,KIF5A,TRIO,DLG4,OBSCN,ARHGEF12,LOC100288637,NUP160,RAC3,CENPP,IQGAP2,RHOU,ARHGAP18,MAD1L1,LOC101928168,FMNL2,KDM4C
R-HSA-373080	Class B/2 (Secretin family receptors)	0.574062131682445	-0.555017645171252	87	4	0.0105820105820106	378	8202	54331,51384,2787,7976	GNG2,WNT16,GNG5,FZD3
R-HSA-168249	Innate Immune System	0.575084547307491	-0.553238210198295	752	34	0.0899470899470899	378	8202	200734,26052,2335,2308,5786,5646,5578,329,8411,5606,6464,8651,10010,7414,5567,843,6709,2254,4893,8831,2247,9140,1742,5682,3093,9636,2260,3667,817,57761,7187,4793,4208,27327	SPRED2,DNM3,FN1,FOXO1,PTPRA,PRSS3,PRKCA,BIRC2,EEA1,MAP2K3,SHC1,SOCS1,TANK,VCL,PRKACB,CASP10,SPTAN1,FGF9,NRAS,SYNGAP1,FGF2,ATG12,DLG4,PSMA1,UBE2K,ISG15,FGFR1,IRS1,CAMK2D,TRIB3,TRAF3,NFKBIB,MEF2C,TNRC6A
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.583111066221647	-0.539377602677129	42	2	0.00529100529100529	378	8202	6659,6934	SOX4,TCF7L2
R-HSA-73777	RNA Polymerase I Chain Elongation	0.583195789198006	-0.539232318481782	88	4	0.0105820105820106	378	8202	2965,2967,64425,25885	GTF2H1,GTF2H3,POLR1E,POLR1A
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.592215953060012	-0.523883925041868	89	4	0.0105820105820106	378	8202	4793,8411,5606,4208	NFKBIB,EEA1,MAP2K3,MEF2C
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.592399845692413	-0.523573457067236	19	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.592399845692413	-0.523573457067236	19	1	0.00264550264550265	378	8202	7846	TUBA1A
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.592399845692413	-0.523573457067236	19	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.592399845692413	-0.523573457067236	19	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-1181150	Signaling by NODAL	0.592399845692413	-0.523573457067236	19	1	0.00264550264550265	378	8202	4088	SMAD3
R-HSA-3928664	Ephrin signaling	0.592399845692413	-0.523573457067236	19	1	0.00264550264550265	378	8202	1948	EFNB2
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.592399845692413	-0.523573457067236	19	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-5617833	Assembly of the primary cilium	0.593486412111957	-0.521740959698361	180	8	0.0211640211640212	378	8202	1778,7846,57539,50807,10806,200894,60412,79659	DYNC1H1,TUBA1A,WDR35,ASAP1,SDCCAG8,ARL13B,EXOC4,DYNC2H1
R-HSA-216083	Integrin cell surface interactions	0.602722818244532	-0.506297859172427	67	3	0.00793650793650794	378	8202	2335,960,3673	FN1,CD44,ITGA2
R-HSA-5663220	RHO GTPases Activate Formins	0.609220566913554	-0.495574898003174	114	5	0.0132275132275132	378	8202	51466,23279,114793,401541,8379	EVL,NUP160,FMNL2,CENPP,MAD1L1
R-HSA-4086400	PCP/CE pathway	0.60990730290899	-0.494448295806521	91	4	0.0105820105820106	378	8202	5682,5578,5881,7976	PSMA1,PRKCA,RAC3,FZD3
R-HSA-109581	Apoptosis	0.610809902124755	-0.492969494038952	160	7	0.0185185185185185	378	8202	5682,7431,317,3836,5366,329,6709	PSMA1,VIM,APAF1,KPNA1,PMAIP1,BIRC2,SPTAN1
R-HSA-1483191	Synthesis of PC	0.61122825316823	-0.492284816464841	20	1	0.00264550264550265	378	8202	9663	LPIN2
R-HSA-210745	Regulation of gene expression in beta cells	0.61122825316823	-0.492284816464841	20	1	0.00264550264550265	378	8202	2308	FOXO1
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.612841343129849	-0.489649196888515	68	3	0.00793650793650794	378	8202	472,23279,3304	ATM,NUP160,HSPA1B
R-HSA-909733	Interferon alpha/beta signaling	0.612841343129849	-0.489649196888515	68	3	0.00793650793650794	378	8202	8651,10581,9636	SOCS1,IFITM2,ISG15
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.618574732231912	-0.480337266264557	92	4	0.0105820105820106	378	8202	4793,8651,5606,4208	NFKBIB,SOCS1,MAP2K3,MEF2C
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.618574732231912	-0.480337266264557	92	4	0.0105820105820106	378	8202	4793,8651,5606,4208	NFKBIB,SOCS1,MAP2K3,MEF2C
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.618574732231912	-0.480337266264557	92	4	0.0105820105820106	378	8202	4793,8651,5606,4208	NFKBIB,SOCS1,MAP2K3,MEF2C
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.618574732231912	-0.480337266264557	92	4	0.0105820105820106	378	8202	4793,8651,5606,4208	NFKBIB,SOCS1,MAP2K3,MEF2C
R-HSA-877300	Interferon gamma signaling	0.618574732231912	-0.480337266264557	92	4	0.0105820105820106	378	8202	817,960,8651,3460	CAMK2D,CD44,SOCS1,IFNGR2
R-HSA-1852241	Organelle biogenesis and maintenance	0.624480591778875	-0.470835027915648	321	14	0.037037037037037	378	8202	1778,80205,7846,57539,50807,133522,10806,200894,60412,92399,55173,6907,79659,4208	DYNC1H1,CHD9,TUBA1A,WDR35,ASAP1,PPARGC1B,SDCCAG8,ARL13B,EXOC4,MRRF,MRPS10,TBL1X,DYNC2H1,MEF2C
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	55824	PAG1
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	162	AP1B1
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	57761	TRIB3
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	4793	NFKBIB
R-HSA-4641263	Regulation of FZD by ubiquitination	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	54894	RNF43
R-HSA-390918	Peroxisomal lipid metabolism	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	51	ACOX1
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	7846	TUBA1A
R-HSA-198753	ERK/MAPK targets	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	4208	MEF2C
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	7324	UBE2E1
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	5646	PRSS3
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.629189108757951	-0.463323417614149	21	1	0.00264550264550265	378	8202	204	AK2
R-HSA-5357801	Programmed Cell Death	0.630427168582752	-0.461357643996016	163	7	0.0185185185185185	378	8202	5682,7431,317,3836,5366,329,6709	PSMA1,VIM,APAF1,KPNA1,PMAIP1,BIRC2,SPTAN1
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.632998832413258	-0.457286701368481	46	2	0.00529100529100529	378	8202	6576,26027	SLC25A1,ACOT11
R-HSA-1483249	Inositol phosphate metabolism	0.632998832413258	-0.457286701368481	46	2	0.00529100529100529	378	8202	23236,8867	PLCB1,SYNJ1
R-HSA-189200	Hexose transport	0.64471943016536	-0.438940048814517	47	2	0.00529100529100529	378	8202	23279,3099	NUP160,HK2
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.646322285238968	-0.436457006046778	22	1	0.00264550264550265	378	8202	9140	ATG12
R-HSA-203765	eNOS activation and regulation	0.646322285238968	-0.436457006046778	22	1	0.00264550264550265	378	8202	115677	NOSTRIN
R-HSA-5205647	Mitophagy	0.646322285238968	-0.436457006046778	22	1	0.00264550264550265	378	8202	9140	ATG12
R-HSA-202131	Metabolism of nitric oxide	0.646322285238968	-0.436457006046778	22	1	0.00264550264550265	378	8202	115677	NOSTRIN
R-HSA-195721	Signaling by Wnt	0.647575788873461	-0.434519443804859	326	14	0.037037037037037	378	8202	54331,79971,7976,5682,54894,51384,5578,6659,23236,5881,2787,6934,27327,22943	GNG2,WLS,FZD3,PSMA1,RNF43,WNT16,PRKCA,SOX4,PLCB1,RAC3,GNG5,TCF7L2,TNRC6A,DKK1
R-HSA-69300	Removal of licensing factors from origins	0.651563306679773	-0.428380716486008	72	3	0.00793650793650794	378	8202	5682,55388,4174	PSMA1,MCM10,MCM5
R-HSA-416476	G alpha (q) signalling events	0.654464625997632	-0.423937742460812	190	8	0.0211640211640212	378	8202	54331,5583,4923,7204,57406,11343,23236,2787	GNG2,PRKCH,NTSR1,TRIO,ABHD6,MGLL,PLCB1,GNG5
R-HSA-73887	Death Receptor Signalling	0.656142677857332	-0.421377016953296	48	2	0.00529100529100529	378	8202	329,843	BIRC2,CASP10
R-HSA-380287	Centrosome maturation	0.660801167522612	-0.41430228994489	73	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.660801167522612	-0.41430228994489	73	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.660801167522612	-0.41430228994489	73	3	0.00793650793650794	378	8202	2744,54541,6834	GLS,DDIT4,SURF1
R-HSA-3700989	Transcriptional Regulation by TP53	0.660801167522612	-0.41430228994489	73	3	0.00793650793650794	378	8202	2744,54541,6834	GLS,DDIT4,SURF1
R-HSA-73980	RNA Polymerase III Transcription Termination	0.662665827562239	-0.411484446688696	23	1	0.00264550264550265	378	8202	4774	NFIA
R-HSA-429947	Deadenylation of mRNA	0.662665827562239	-0.411484446688696	23	1	0.00264550264550265	378	8202	5073	PARN
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.662665827562239	-0.411484446688696	23	1	0.00264550264550265	378	8202	7324	UBE2E1
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.662665827562239	-0.411484446688696	23	1	0.00264550264550265	378	8202	6827	SUPT4H1
R-HSA-112409	RAF-independent MAPK1/3 activation	0.662665827562239	-0.411484446688696	23	1	0.00264550264550265	378	8202	3570	IL6R
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.662665827562239	-0.411484446688696	23	1	0.00264550264550265	378	8202	6857	SYT1
R-HSA-201451	Signaling by BMP	0.662665827562239	-0.411484446688696	23	1	0.00264550264550265	378	8202	4092	SMAD7
R-HSA-2187338	Visual phototransduction	0.667994415518345	-0.403475465482914	98	4	0.0105820105820106	378	8202	5578,5947,157506,4647	PRKCA,RBP1,RDH10,MYO7A
R-HSA-5610787	Hedgehog 'off' state	0.67579092647934	-0.391871531132211	99	4	0.0105820105820106	378	8202	5682,79659,57539,5567	PSMA1,DYNC2H1,WDR35,PRKACB
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.678107280404856	-0.388449772873267	50	2	0.00529100529100529	378	8202	5682,1019	PSMA1,CDK4
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.678107280404856	-0.388449772873267	50	2	0.00529100529100529	378	8202	5682,1019	PSMA1,CDK4
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.678107280404856	-0.388449772873267	50	2	0.00529100529100529	378	8202	5682,4953	PSMA1,ODC1
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	2308	FOXO1
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	23365	ARHGEF12
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	9871	SEC24D
R-HSA-70268	Pyruvate metabolism	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	6566	SLC16A1
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	4208	MEF2C
R-HSA-933542	TRAF6 mediated NF-kB activation	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	4793	NFKBIB
R-HSA-5365859	RA biosynthesis pathway	0.678256036282627	-0.388230427692611	24	1	0.00264550264550265	378	8202	157506	RDH10
R-HSA-3214858	RMTs methylate histone arginines	0.678743074957513	-0.387512610426904	75	3	0.00793650793650794	378	8202	57492,317772,1019	ARID1B,HIST2H2AB,CDK4
R-HSA-69304	Regulation of DNA replication	0.678743074957513	-0.387512610426904	75	3	0.00793650793650794	378	8202	5682,55388,4174	PSMA1,MCM10,MCM5
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.68865468750864	-0.373015312833512	51	2	0.00529100529100529	378	8202	3373,1462	HYAL1,VCAN
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.68865468750864	-0.373015312833512	51	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-5673000	RAF activation	0.693127547455916	-0.366541245564633	25	1	0.00264550264550265	378	8202	4893	NRAS
R-HSA-114452	Activation of BH3-only proteins	0.693127547455916	-0.366541245564633	25	1	0.00264550264550265	378	8202	5366	PMAIP1
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.698916767264205	-0.358223617852213	52	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.698916767264205	-0.358223617852213	52	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-69541	Stabilization of p53	0.698916767264205	-0.358223617852213	52	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-69610	p53-Independent DNA Damage Response	0.698916767264205	-0.358223617852213	52	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	4793	NFKBIB
R-HSA-3781865	Diseases of glycosylation	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	4793	NFKBIB
R-HSA-912694	Regulation of IFNA signaling	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	8651	SOCS1
R-HSA-983189	Kinesins	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	3798	KIF5A
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	1462	VCAN
R-HSA-77387	Insulin receptor recycling	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	535	ATP6V0A1
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.707313408660958	-0.3462814175899	26	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-381038	XBP1(S) activates chaperone genes	0.708897340395717	-0.344044557862274	53	2	0.00529100529100529	378	8202	7709,6464	ZBTB17,SHC1
R-HSA-1640170	Cell Cycle	0.716941300408474	-0.3327613100624	572	24	0.0634920634920635	378	8202	8924,5984,114799,5983,55388,7846,328,1019,5682,672,5578,23279,7324,401541,54386,1778,9577,4174,10806,9663,8379,472,1021,7112	HERC2,RFC4,ESCO1,RFC3,MCM10,TUBA1A,APEX1,CDK4,PSMA1,BRCA1,PRKCA,NUP160,UBE2E1,CENPP,TERF2IP,DYNC1H1,BRE,MCM5,SDCCAG8,LPIN2,MAD1L1,ATM,CDK6,TMPO
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.718600481717156	-0.33044973394787	54	2	0.00529100529100529	378	8202	1462,9653	VCAN,HS2ST1
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.719886756822228	-0.328661361533527	105	4	0.0105820105820106	378	8202	1021,1019,7324,79813	CDK6,CDK4,UBE2E1,EHMT1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.720845151743926	-0.327330933495714	27	1	0.00264550264550265	378	8202	7846	TUBA1A
R-HSA-182971	EGFR downregulation	0.720845151743926	-0.327330933495714	27	1	0.00264550264550265	378	8202	5796	PTPRK
R-HSA-400685	Sema4D in semaphorin signaling	0.720845151743926	-0.327330933495714	27	1	0.00264550264550265	378	8202	23365	ARHGEF12
R-HSA-381070	IRE1alpha activates chaperones	0.728030488789842	-0.317412351456576	55	2	0.00529100529100529	378	8202	7709,6464	ZBTB17,SHC1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.728030488789842	-0.317412351456576	55	2	0.00529100529100529	378	8202	5682,3304	PSMA1,HSPA1B
R-HSA-611105	Respiratory electron transport	0.728324583736875	-0.317008473368631	81	3	0.00793650793650794	378	8202	2110,4725,6834	ETFDH,NDUFS5,SURF1
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.728324583736875	-0.317008473368631	81	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.733752862164581	-0.309583007112064	28	1	0.00264550264550265	378	8202	162	AP1B1
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.733752862164581	-0.309583007112064	28	1	0.00264550264550265	378	8202	57761	TRIB3
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.733752862164581	-0.309583007112064	28	1	0.00264550264550265	378	8202	7846	TUBA1A
R-HSA-68874	M/G1 Transition	0.735978091950031	-0.306554927068528	82	3	0.00793650793650794	378	8202	5682,55388,4174	PSMA1,MCM10,MCM5
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.735978091950031	-0.306554927068528	82	3	0.00793650793650794	378	8202	4793,5606,4208	NFKBIB,MAP2K3,MEF2C
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.735978091950031	-0.306554927068528	82	3	0.00793650793650794	378	8202	4793,5606,4208	NFKBIB,MAP2K3,MEF2C
R-HSA-69002	DNA Replication Pre-Initiation	0.735978091950031	-0.306554927068528	82	3	0.00793650793650794	378	8202	5682,55388,4174	PSMA1,MCM10,MCM5
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.735978091950031	-0.306554927068528	82	3	0.00793650793650794	378	8202	4793,5606,4208	NFKBIB,MAP2K3,MEF2C
R-HSA-168256	Immune System	0.743137822381805	-0.296873757009005	1371	59	0.156084656084656	378	8202	8924,200734,26052,2335,2308,9871,5786,3798,5646,55740,162,5578,23279,10666,329,8411,55824,2317,5606,6464,8651,10010,51164,26046,79659,960,7414,90678,5567,843,6709,2254,51466,4893,8831,3460,2247,5682,1742,9140,535,3570,3093,9636,2260,7324,1525,114876,1778,3667,57761,817,3836,57630,7187,10581,4793,27327,4208	HERC2,SPRED2,DNM3,FN1,FOXO1,SEC24D,PTPRA,KIF5A,PRSS3,ENAH,AP1B1,PRKCA,NUP160,CD226,BIRC2,EEA1,PAG1,FLNB,MAP2K3,SHC1,SOCS1,TANK,DCTN4,LTN1,DYNC2H1,CD44,VCL,LRSAM1,PRKACB,CASP10,SPTAN1,FGF9,EVL,NRAS,SYNGAP1,IFNGR2,FGF2,PSMA1,DLG4,ATG12,ATP6V0A1,IL6R,UBE2K,ISG15,FGFR1,UBE2E1,CXADR,OSBPL1A,DYNC1H1,IRS1,TRIB3,CAMK2D,KPNA1,SH3RF1,TRAF3,IFITM2,NFKBIB,TNRC6A,MEF2C
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.74346064509403	-0.296439446434413	83	3	0.00793650793650794	378	8202	4793,5606,4208	NFKBIB,MAP2K3,MEF2C
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.746065245104254	-0.292942222677499	29	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.746065245104254	-0.292942222677499	29	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.746065245104254	-0.292942222677499	29	1	0.00264550264550265	378	8202	27327	TNRC6A
R-HSA-917977	Transferrin endocytosis and recycling	0.746065245104254	-0.292942222677499	29	1	0.00264550264550265	378	8202	535	ATP6V0A1
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.746089231844943	-0.29291007219836	57	2	0.00529100529100529	378	8202	6907,182	TBL1X,JAG1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.746089231844943	-0.29291007219836	57	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.746089231844943	-0.29291007219836	57	2	0.00529100529100529	378	8202	6907,182	TBL1X,JAG1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.746089231844943	-0.29291007219836	57	2	0.00529100529100529	378	8202	6907,182	TBL1X,JAG1
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.746089231844943	-0.29291007219836	57	2	0.00529100529100529	378	8202	6907,182	TBL1X,JAG1
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.746089231844943	-0.29291007219836	57	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.746089231844943	-0.29291007219836	57	2	0.00529100529100529	378	8202	6907,182	TBL1X,JAG1
R-HSA-912446	Meiotic recombination	0.750773815397038	-0.286650850481257	84	3	0.00793650793650794	378	8202	472,672,1019	ATM,BRCA1,CDK4
R-HSA-351202	Metabolism of polyamines	0.750773815397038	-0.286650850481257	84	3	0.00793650793650794	378	8202	5682,6723,4953	PSMA1,SRM,ODC1
R-HSA-453279	Mitotic G1-G1/S phases	0.752274436084349	-0.284654080005759	135	5	0.0132275132275132	378	8202	5682,55388,4174,1021,1019	PSMA1,MCM10,MCM5,CDK6,CDK4
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.757809688675342	-0.277322995212355	30	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.757809688675342	-0.277322995212355	30	1	0.00264550264550265	378	8202	4208	MEF2C
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.757809688675342	-0.277322995212355	30	1	0.00264550264550265	378	8202	6464	SHC1
R-HSA-5683826	Surfactant metabolism	0.757809688675342	-0.277322995212355	30	1	0.00264550264550265	378	8202	2627	GATA6
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.757919294154595	-0.277178371099884	85	3	0.00793650793650794	378	8202	4793,5606,4208	NFKBIB,MAP2K3,MEF2C
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.757919294154595	-0.277178371099884	85	3	0.00793650793650794	378	8202	4793,5606,4208	NFKBIB,MAP2K3,MEF2C
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.763111353883642	-0.270351316165809	59	2	0.00529100529100529	378	8202	5682,5567	PSMA1,PRKACB
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.763111353883642	-0.270351316165809	59	2	0.00529100529100529	378	8202	5682,5567	PSMA1,PRKACB
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.763111353883642	-0.270351316165809	59	2	0.00529100529100529	378	8202	5682,5567	PSMA1,PRKACB
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.763608687732356	-0.269699809861117	137	5	0.0132275132275132	378	8202	10019,2627,3798,5567,5890	SH2B3,GATA6,KIF5A,PRKACB,RAD51B
R-HSA-1474290	Collagen formation	0.764898882155833	-0.268011634080626	86	3	0.00793650793650794	378	8202	667,4316,3691	DST,MMP7,ITGB4
R-HSA-71291	Metabolism of amino acids and derivatives	0.768137185596091	-0.263786934708138	212	8	0.0211640211640212	378	8202	6723,2744,440,29968,5682,5832,4953,5831	SRM,GLS,ASNS,PSAT1,PSMA1,ALDH18A1,ODC1,PYCR1
R-HSA-2129379	Molecules associated with elastic fibres	0.769012324213531	-0.262648283319436	31	1	0.00264550264550265	378	8202	652	BMP4
R-HSA-168638	NOD1/2 Signaling Pathway	0.769012324213531	-0.262648283319436	31	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-418990	Adherens junctions interactions	0.769012324213531	-0.262648283319436	31	1	0.00264550264550265	378	8202	25945	PVRL3
R-HSA-70171	Glycolysis	0.769012324213531	-0.262648283319436	31	1	0.00264550264550265	378	8202	3099	HK2
R-HSA-5357905	Regulation of TNFR1 signaling	0.769012324213531	-0.262648283319436	31	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-2022928	HS-GAG biosynthesis	0.769012324213531	-0.262648283319436	31	1	0.00264550264550265	378	8202	9653	HS2ST1
R-HSA-180746	Nuclear import of Rev protein	0.769012324213531	-0.262648283319436	31	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-69615	G1/S DNA Damage Checkpoints	0.771246033102051	-0.259747847241503	60	2	0.00529100529100529	378	8202	5682,472	PSMA1,ATM
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.771246033102051	-0.259747847241503	60	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-450294	MAP kinase activation in TLR cascade	0.771246033102051	-0.259747847241503	60	2	0.00529100529100529	378	8202	5606,4208	MAP2K3,MEF2C
R-HSA-73923	Lipid digestion, mobilization, and transport	0.771246033102051	-0.259747847241503	60	2	0.00529100529100529	378	8202	11343,5567	MGLL,PRKACB
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.779136559151627	-0.249568947894987	61	2	0.00529100529100529	378	8202	1591,6916	CYP24A1,TBXAS1
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.779698083790449	-0.248848506293754	32	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-1980145	Signaling by NOTCH2	0.779698083790449	-0.248848506293754	32	1	0.00264550264550265	378	8202	182	JAG1
R-HSA-186712	Regulation of beta-cell development	0.779698083790449	-0.248848506293754	32	1	0.00264550264550265	378	8202	2308	FOXO1
R-HSA-389356	CD28 co-stimulation	0.779698083790449	-0.248848506293754	32	1	0.00264550264550265	378	8202	57761	TRIB3
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.779698083790449	-0.248848506293754	32	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-69278	Cell Cycle, Mitotic	0.78002202696217	-0.248433120002142	477	19	0.0502645502645503	378	8202	5984,114799,5983,55388,7846,328,1019,5682,5578,23279,7324,401541,1778,4174,10806,9663,8379,1021,7112	RFC4,ESCO1,RFC3,MCM10,TUBA1A,APEX1,CDK4,PSMA1,PRKCA,NUP160,UBE2E1,CENPP,DYNC1H1,MCM5,SDCCAG8,LPIN2,MAD1L1,CDK6,TMPO
R-HSA-202403	TCR signaling	0.78326523110397	-0.244283903307666	115	4	0.0105820105820106	378	8202	5682,55740,51466,55824	PSMA1,ENAH,EVL,PAG1
R-HSA-1500620	Meiosis	0.78326523110397	-0.244283903307666	115	4	0.0105820105820106	378	8202	54386,472,672,1019	TERF2IP,ATM,BRCA1,CDK4
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.786788088488764	-0.23979633176744	62	2	0.00529100529100529	378	8202	22989,60412	MYH15,EXOC4
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.789890755062165	-0.235860627814721	33	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-933541	TRAF6 mediated IRF7 activation	0.789890755062165	-0.235860627814721	33	1	0.00264550264550265	378	8202	10010	TANK
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.789890755062165	-0.235860627814721	33	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-4085001	Sialic acid metabolism	0.789890755062165	-0.235860627814721	33	1	0.00264550264550265	378	8202	8869	ST3GAL5
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.791197667418202	-0.234207446834955	90	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-597592	Post-translational protein modification	0.794144260361893	-0.230490146125073	411	16	0.0423280423280423	378	8202	8924,9871,22955,672,79642,23279,8869,4121,1912,149111,286053,197370,89978,55568,648,7518	HERC2,SEC24D,SCMH1,BRCA1,ARSJ,NUP160,ST3GAL5,MAN1A1,PHC2,CNIH3,NSMCE2,NSMCE1,DPH6,GALNT10,BMI1,XRCC4
R-HSA-4608870	Asymmetric localization of PCP proteins	0.794205821960418	-0.230412629714501	63	2	0.00529100529100529	378	8202	5682,7976	PSMA1,FZD3
R-HSA-3214847	HATs acetylate histones	0.795261822838484	-0.229083881643545	143	5	0.0132275132275132	378	8202	57634,23587,55689,317772,7994	EP400,ELP5,YEATS2,HIST2H2AB,KAT6A
R-HSA-212436	Generic Transcription Pathway	0.796482853469367	-0.227549677209178	553	22	0.0582010582010582	378	8202	9534,171392,51123,80205,10780,7748,340252,5468,2649,4092,7025,54541,4088,2744,6498,93134,54807,28996,51586,6834,80264,6907	ZNF254,ZNF675,ZNF706,CHD9,ZNF234,ZNF195,ZNF680,PPARG,NR6A1,SMAD7,NR2F1,DDIT4,SMAD3,GLS,SKIL,ZNF561,ZNF586,HIPK2,MED15,SURF1,ZNF430,TBL1X
R-HSA-1222556	ROS production in response to bacteria	0.799613033761538	-0.223627376136643	34	1	0.00264550264550265	378	8202	535	ATP6V0A1
R-HSA-177243	Interactions of Rev with host cellular proteins	0.799613033761538	-0.223627376136643	34	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.799613033761538	-0.223627376136643	34	1	0.00264550264550265	378	8202	5578	PRKCA
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.801394989787264	-0.221401332624861	64	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-432720	Lysosome Vesicle Biogenesis	0.808886573582893	-0.212096577460562	35	1	0.00264550264550265	378	8202	162	AP1B1
R-HSA-2514856	The phototransduction cascade	0.808886573582893	-0.212096577460562	35	1	0.00264550264550265	378	8202	5578	PRKCA
R-HSA-194068	Bile acid and bile salt metabolism	0.808886573582893	-0.212096577460562	35	1	0.00264550264550265	378	8202	8714	ABCC3
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.808886573582893	-0.212096577460562	35	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-68882	Mitotic Anaphase	0.811329330446151	-0.209081227829632	172	6	0.0158730158730159	378	8202	5682,23279,7324,401541,7112,8379	PSMA1,NUP160,UBE2E1,CENPP,TMPO,MAD1L1
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.813787927718706	-0.206055477981809	223	8	0.0211640211640212	378	8202	8924,8651,57630,26046,5682,90678,3093,7324	HERC2,SOCS1,SH3RF1,LTN1,PSMA1,LRSAM1,UBE2K,UBE2E1
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.815108615306798	-0.204433904305884	66	2	0.00529100529100529	378	8202	9871,149111	SEC24D,CNIH3
R-HSA-1169091	Activation of NF-kappaB in B cells	0.815108615306798	-0.204433904305884	66	2	0.00529100529100529	378	8202	5682,4793	PSMA1,NFKBIB
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.815630380544016	-0.203793991657263	173	6	0.0158730158730159	378	8202	5682,23279,7324,401541,7112,8379	PSMA1,NUP160,UBE2E1,CENPP,TMPO,MAD1L1
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.817732033975965	-0.201220582874123	36	1	0.00264550264550265	378	8202	1591	CYP24A1
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.817732033975965	-0.201220582874123	36	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.817732033975965	-0.201220582874123	36	1	0.00264550264550265	378	8202	10087	COL4A3BP
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.817732033975965	-0.201220582874123	36	1	0.00264550264550265	378	8202	6464	SHC1
R-HSA-948021	Transport to the Golgi and subsequent modification	0.820590207988546	-0.197731431791353	95	3	0.00793650793650794	378	8202	9871,149111,4121	SEC24D,CNIH3,MAN1A1
R-HSA-373755	Semaphorin interactions	0.821643562921074	-0.196448599717574	67	2	0.00529100529100529	378	8202	23365,8829	ARHGEF12,NRP1
R-HSA-68867	Assembly of the pre-replicative complex	0.821643562921074	-0.196448599717574	67	2	0.00529100529100529	378	8202	5682,4174	PSMA1,MCM5
R-HSA-1632852	Macroautophagy	0.821643562921074	-0.196448599717574	67	2	0.00529100529100529	378	8202	9140,92421	ATG12,CHMP4C
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.826027924744098	-0.191126698836365	96	3	0.00793650793650794	378	8202	5682,7187,329	PSMA1,TRAF3,BIRC2
R-HSA-419037	NCAM1 interactions	0.826169125727352	-0.190955773723579	37	1	0.00264550264550265	378	8202	783	CACNB2
R-HSA-199977	ER to Golgi Anterograde Transport	0.827970902907802	-0.18877726663005	68	2	0.00529100529100529	378	8202	9871,149111	SEC24D,CNIH3
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.834095829507745	-0.181406979737785	69	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.834095829507745	-0.181406979737785	69	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.834216654266738	-0.181262133061424	38	1	0.00264550264550265	378	8202	10038	PARP2
R-HSA-156580	Phase II conjugation	0.836482215236779	-0.178550019705628	98	3	0.00793650793650794	378	8202	2678,6819,4257	GGT1,SULT1C2,MGST1
R-HSA-68949	Orc1 removal from chromatin	0.840023500436276	-0.174325410826266	70	2	0.00529100529100529	378	8202	5682,4174	PSMA1,MCM5
R-HSA-69052	Switching of origins to a post-replicative state	0.840023500436276	-0.174325410826266	70	2	0.00529100529100529	378	8202	5682,4174	PSMA1,MCM5
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.840023500436276	-0.174325410826266	70	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-2672351	Stimuli-sensing channels	0.841503817996917	-0.172564728229167	99	3	0.00793650793650794	378	8202	6262,57719,10110	RYR2,ANO8,SGK2
R-HSA-1296071	Potassium Channels	0.841503817996917	-0.172564728229167	99	3	0.00793650793650794	378	8202	54331,23416,2787	GNG2,KCNH3,GNG5
R-HSA-162909	Host Interactions of HIV factors	0.843690992134332	-0.16996897448918	127	4	0.0105820105820106	378	8202	5682,3836,162,23279	PSMA1,KPNA1,AP1B1,NUP160
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.84639177177801	-0.166772939359653	100	3	0.00793650793650794	378	8202	23279,401541,8379	NUP160,CENPP,MAD1L1
R-HSA-5675221	Negative regulation of MAPK pathway	0.849213964145862	-0.163444105404742	40	1	0.00264550264550265	378	8202	4893	NRAS
R-HSA-1660662	Glycosphingolipid metabolism	0.849213964145862	-0.163444105404742	40	1	0.00264550264550265	378	8202	79642	ARSJ
R-HSA-109703	PKB-mediated events	0.849213964145862	-0.163444105404742	40	1	0.00264550264550265	378	8202	5140	PDE3B
R-HSA-1980143	Signaling by NOTCH1	0.851307478451722	-0.160981901387704	72	2	0.00529100529100529	378	8202	6907,182	TBL1X,JAG1
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.851307478451722	-0.160981901387704	72	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.855776928969685	-0.155745533799724	102	3	0.00793650793650794	378	8202	2110,4725,6834	ETFDH,NDUFS5,SURF1
R-HSA-168325	Viral Messenger RNA Synthesis	0.856197193930392	-0.155254562629626	41	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-75893	TNF signaling	0.856197193930392	-0.155254562629626	41	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.856673853416726	-0.154698000593767	73	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-373752	Netrin-1 signaling	0.86285783119971	-0.1475053393609	42	1	0.00264550264550265	378	8202	7204	TRIO
R-HSA-3928662	EPHB-mediated forward signaling	0.86285783119971	-0.1475053393609	42	1	0.00264550264550265	378	8202	1948	EFNB2
R-HSA-975634	Retinoid metabolism and transport	0.86285783119971	-0.1475053393609	42	1	0.00264550264550265	378	8202	5947	RBP1
R-HSA-375280	Amine ligand-binding receptors	0.86285783119971	-0.1475053393609	42	1	0.00264550264550265	378	8202	3363	HTR7
R-HSA-1566948	Elastic fibre formation	0.86285783119971	-0.1475053393609	42	1	0.00264550264550265	378	8202	652	BMP4
R-HSA-1221632	Meiotic synapsis	0.866880083679937	-0.1428546235554	75	2	0.00529100529100529	378	8202	54386,672	TERF2IP,BRCA1
R-HSA-1296072	Voltage gated Potassium channels	0.869210740496867	-0.14016967391497	43	1	0.00264550264550265	378	8202	23416	KCNH3
R-HSA-2467813	Separation of Sister Chromatids	0.870543699986426	-0.138637320015627	161	5	0.0132275132275132	378	8202	5682,23279,7324,401541,8379	PSMA1,NUP160,UBE2E1,CENPP,MAD1L1
R-HSA-428157	Sphingolipid metabolism	0.871729617456136	-0.137275974879949	76	2	0.00529100529100529	378	8202	79642,10087	ARSJ,COL4A3BP
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.874022375941759	-0.134649301890295	267	9	0.0238095238095238	378	8202	8924,8651,9871,57630,5682,26046,90678,3093,7324	HERC2,SOCS1,SEC24D,SH3RF1,PSMA1,LTN1,LRSAM1,UBE2K,UBE2E1
R-HSA-5362517	Signaling by Retinoic Acid	0.875270103167222	-0.133222750925304	44	1	0.00264550264550265	378	8202	157506	RDH10
R-HSA-5358351	Signaling by Hedgehog	0.875580788226724	-0.132867854841017	135	4	0.0105820105820106	378	8202	5682,79659,57539,5567	PSMA1,DYNC2H1,WDR35,PRKACB
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.876416425857542	-0.131913929015717	77	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-68875	Mitotic Prophase	0.879144111189546	-0.128806445714033	136	4	0.0105820105820106	378	8202	5578,23279,9663,7112	PRKCA,NUP160,LPIN2,TMPO
R-HSA-68877	Mitotic Prometaphase	0.880990026889606	-0.126708973326143	108	3	0.00793650793650794	378	8202	23279,401541,8379	NUP160,CENPP,MAD1L1
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.881049448723341	-0.126641526671764	45	1	0.00264550264550265	378	8202	27327	TNRC6A
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.881049448723341	-0.126641526671764	45	1	0.00264550264550265	378	8202	6566	SLC16A1
R-HSA-69206	G1/S Transition	0.884789712776473	-0.122405274890525	109	3	0.00793650793650794	378	8202	5682,55388,4174	PSMA1,MCM10,MCM5
R-HSA-157118	Signaling by NOTCH	0.888481066389802	-0.118241941248922	110	3	0.00793650793650794	378	8202	6907,182,27327	TBL1X,JAG1,TNRC6A
R-HSA-211859	Biological oxidations	0.889257891875041	-0.117367993438901	194	6	0.0158730158730159	378	8202	1591,2678,1800,6819,4257,6916	CYP24A1,GGT1,DPEP1,SULT1C2,MGST1,TBXAS1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.891819124955555	-0.114491941677203	47	1	0.00264550264550265	378	8202	329	BIRC2
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.891819124955555	-0.114491941677203	47	1	0.00264550264550265	378	8202	6907	TBL1X
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.893628147994494	-0.112465532177036	81	2	0.00529100529100529	378	8202	5682,6934	PSMA1,TCF7L2
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.896833517444652	-0.108885033430343	48	1	0.00264550264550265	378	8202	1948	EFNB2
R-HSA-72163	mRNA Splicing - Major Pathway	0.898929595106443	-0.106550562253086	113	3	0.00793650793650794	378	8202	10946,2521,27339	SF3A3,FUS,PRPF19
R-HSA-453276	Regulation of mitotic cell cycle	0.901374553816567	-0.103834398748451	83	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.901374553816567	-0.103834398748451	83	2	0.00529100529100529	378	8202	5682,7324	PSMA1,UBE2E1
R-HSA-390466	Chaperonin-mediated protein folding	0.901616069617104	-0.103566492971413	49	1	0.00264550264550265	378	8202	7846	TUBA1A
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.901616069617104	-0.103566492971413	49	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-936837	Ion transport by P-type ATPases	0.901616069617104	-0.103566492971413	49	1	0.00264550264550265	378	8202	51076	CUTC
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.901616069617104	-0.103566492971413	49	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-171306	Packaging Of Telomere Ends	0.901616069617104	-0.103566492971413	49	1	0.00264550264550265	378	8202	54386	TERF2IP
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.901697913547499	-0.103475722388791	143	4	0.0105820105820106	378	8202	6566,2110,4725,6834	SLC16A1,ETFDH,NDUFS5,SURF1
R-HSA-5419276	Mitochondrial translation termination	0.905047742560994	-0.0997675824626229	84	2	0.00529100529100529	378	8202	92399,55173	MRRF,MRPS10
R-HSA-69275	G2/M Transition	0.905398031964762	-0.0993806176464784	115	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.906177473495898	-0.0985201052616693	50	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-169911	Regulation of Apoptosis	0.906177473495898	-0.0985201052616693	50	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-429914	Deadenylation-dependent mRNA decay	0.906177473495898	-0.0985201052616693	50	1	0.00264550264550265	378	8202	5073	PARN
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.906177473495898	-0.0985201052616693	50	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-392499	Metabolism of proteins	0.90824574195175	-0.0962402960814655	943	36	0.0952380952380952	378	8202	8924,9871,3798,4240,8604,3800,79642,6748,23279,5073,4121,148867,1912,440,6464,149111,89978,7709,468,7846,617,22955,672,8869,6934,9709,10469,2627,197370,286053,60412,1803,55568,8891,648,7518	HERC2,SEC24D,KIF5A,MFGE8,SLC25A12,KIF5C,ARSJ,SSR4,NUP160,PARN,MAN1A1,SLC30A7,PHC2,ASNS,SHC1,CNIH3,DPH6,ZBTB17,ATF4,TUBA1A,BCS1L,SCMH1,BRCA1,ST3GAL5,TCF7L2,HERPUD1,TIMM44,GATA6,NSMCE1,NSMCE2,EXOC4,DPP4,GALNT10,EIF2B3,BMI1,XRCC4
R-HSA-1461973	Defensins	0.910527929202219	-0.0937307057080829	51	1	0.00264550264550265	378	8202	5646	PRSS3
R-HSA-180534	Vpu mediated degradation of CD4	0.910527929202219	-0.0937307057080829	51	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-453274	Mitotic G2-G2/M phases	0.91149057939008	-0.0926740201992425	117	3	0.00793650793650794	378	8202	1778,7846,10806	DYNC1H1,TUBA1A,SDCCAG8
R-HSA-168254	Influenza Infection	0.912849201572875	-0.0911845800761476	147	4	0.0105820105820106	378	8202	3836,23279,9636,3304	KPNA1,NUP160,ISG15,HSPA1B
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.91467716766432	-0.0891840981878078	52	1	0.00264550264550265	378	8202	8869	ST3GAL5
R-HSA-195258	RHO GTPase Effectors	0.915224261043945	-0.0885861497001538	285	9	0.0238095238095238	378	8202	51466,3798,8379,1742,23279,114793,23081,10788,401541	EVL,KIF5A,MAD1L1,DLG4,NUP160,FMNL2,KDM4C,IQGAP2,CENPP
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.918634472048688	-0.0848669810705307	53	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-72172	mRNA Splicing	0.919964352402633	-0.0834203570781934	120	3	0.00793650793650794	378	8202	10946,2521,27339	SF3A3,FUS,PRPF19
R-HSA-211945	Phase 1 - Functionalization of compounds	0.92157244020704	-0.0816738937768887	89	2	0.00529100529100529	378	8202	1591,6916	CYP24A1,TBXAS1
R-HSA-114604	GPVI-mediated activation cascade	0.9224086982761	-0.0807668800239409	54	1	0.00264550264550265	378	8202	6464	SHC1
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.9224086982761	-0.0807668800239409	54	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-4641257	Degradation of AXIN	0.9224086982761	-0.0807668800239409	54	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.9224086982761	-0.0807668800239409	54	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.9224086982761	-0.0807668800239409	54	1	0.00264550264550265	378	8202	162	AP1B1
R-HSA-5368287	Mitochondrial translation	0.924535503215555	-0.0784638262794953	90	2	0.00529100529100529	378	8202	92399,55173	MRRF,MRPS10
R-HSA-391251	Protein folding	0.926008294748936	-0.0768720867638351	55	1	0.00264550264550265	378	8202	7846	TUBA1A
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.926008294748936	-0.0768720867638351	55	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.926008294748936	-0.0768720867638351	55	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.927471933681825	-0.0752927451397164	153	4	0.0105820105820106	378	8202	10946,2521,23279,27339	SF3A3,FUS,NUP160,PRPF19
R-HSA-5621481	C-type lectin receptors (CLRs)	0.927692582946526	-0.0750548694540137	123	3	0.00793650793650794	378	8202	5682,4893,5567	PSMA1,NRAS,PRKACB
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.929441320968982	-0.0731716034863617	56	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-4641258	Degradation of DVL	0.929441320968982	-0.0731716034863617	56	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.935838062608893	-0.0663128275057416	58	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.935838062608893	-0.0663128275057416	58	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.938816109289343	-0.0631356557049588	59	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-421270	Cell-cell junction organization	0.944364942100601	-0.0572425963354999	61	1	0.00264550264550265	378	8202	25945	PVRL3
R-HSA-5578749	Transcriptional regulation by small RNAs	0.95086643295317	-0.0503816753509322	101	2	0.00529100529100529	378	8202	23279,27327	NUP160,TNRC6A
R-HSA-5358346	Hedgehog ligand biogenesis	0.951761227924273	-0.0494410866530264	64	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-913709	O-linked glycosylation of mucins	0.951761227924273	-0.0494410866530264	64	1	0.00264550264550265	378	8202	55568	GALNT10
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.951761227924273	-0.0494410866530264	64	1	0.00264550264550265	378	8202	23081	KDM4C
R-HSA-1236974	ER-Phagosome pathway	0.951761227924273	-0.0494410866530264	64	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-168255	Influenza Life Cycle	0.953883658108073	-0.047213566639247	136	3	0.00793650793650794	378	8202	3836,23279,3304	KPNA1,NUP160,HSPA1B
R-HSA-69202	Cyclin E associated events during G1/S transition	0.954001859020292	-0.0470896588771621	65	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-983712	Ion channel transport	0.954687121917868	-0.046371613209311	198	5	0.0132275132275132	378	8202	535,6262,57719,10110,51076	ATP6V0A1,RYR2,ANO8,SGK2,CUTC
R-HSA-199991	Membrane Trafficking	0.95496698699806	-0.0460785076873334	256	7	0.0185185185185185	378	8202	22989,162,149111,9871,79720,60412,92421	MYH15,AP1B1,CNIH3,SEC24D,VPS37B,EXOC4,CHMP4C
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.956138678146041	-0.0448523156288204	66	1	0.00264550264550265	378	8202	4793	NFKBIB
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.956138678146041	-0.0448523156288204	66	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.958176482938204	-0.0427232977917151	67	1	0.00264550264550265	378	8202	8869	ST3GAL5
R-HSA-388841	Costimulation by the CD28 family	0.960119849794781	-0.0406971587763302	68	1	0.00264550264550265	378	8202	57761	TRIB3
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.96374053035366	-0.03693317998565	70	1	0.00264550264550265	378	8202	401541	CENPP
R-HSA-421837	Clathrin derived vesicle budding	0.96374053035366	-0.03693317998565	70	1	0.00264550264550265	378	8202	162	AP1B1
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.96374053035366	-0.03693317998565	70	1	0.00264550264550265	378	8202	162	AP1B1
R-HSA-774815	Nucleosome assembly	0.96374053035366	-0.03693317998565	70	1	0.00264550264550265	378	8202	401541	CENPP
R-HSA-68886	M Phase	0.96707263793626	-0.0334816695596259	296	8	0.0211640211640212	378	8202	9663,8379,5682,5578,23279,7324,7112,401541	LPIN2,MAD1L1,PSMA1,PRKCA,NUP160,UBE2E1,TMPO,CENPP
R-HSA-446203	Asparagine N-linked glycosylation	0.970518479219486	-0.0299248356275213	181	4	0.0105820105820106	378	8202	9871,149111,8869,4121	SEC24D,CNIH3,ST3GAL5,MAN1A1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.97190303292266	-0.0284992398657283	115	2	0.00529100529100529	378	8202	10666,1525	CD226,CXADR
R-HSA-2871837	FCERI mediated NF-kB activation	0.974018409606463	-0.0263250744848949	77	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-1236975	Antigen processing-Cross presentation	0.978527093959566	-0.0217068032502816	81	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-5632684	Hedgehog 'on' state	0.981388463156303	-0.0187869108913516	84	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-5389840	Mitochondrial translation elongation	0.981388463156303	-0.0187869108913516	84	1	0.00264550264550265	378	8202	55173	MRPS10
R-HSA-5368286	Mitochondrial translation initiation	0.981388463156303	-0.0187869108913516	84	1	0.00264550264550265	378	8202	55173	MRPS10
R-HSA-201681	TCF dependent signaling in response to WNT	0.982792431147997	-0.0173573396793823	229	5	0.0132275132275132	378	8202	5682,54894,6659,6934,22943	PSMA1,RNF43,SOX4,TCF7L2,DKK1
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.98386941426759	-0.0162620998141646	87	1	0.00264550264550265	378	8202	6934	TCF7L2
R-HSA-5653656	Vesicle-mediated transport	0.984619680258694	-0.015499823782746	294	7	0.0185185185185185	378	8202	22989,162,149111,9871,79720,60412,92421	MYH15,AP1B1,CNIH3,SEC24D,VPS37B,EXOC4,CHMP4C
R-HSA-977225	Amyloid formation	0.984620783509697	-0.0154987032989619	88	1	0.00264550264550265	378	8202	4240	MFGE8
R-HSA-211000	Gene Silencing by RNA	0.984762876478808	-0.0153544013305403	130	2	0.00529100529100529	378	8202	23279,27327	NUP160,TNRC6A
R-HSA-5625740	RHO GTPases activate PKNs	0.986020407558027	-0.014078227273174	90	1	0.00264550264550265	378	8202	23081	KDM4C
R-HSA-2682334	EPH-Ephrin signaling	0.988988424453191	-0.0110726517219638	95	1	0.00264550264550265	378	8202	1948	EFNB2
R-HSA-202424	Downstream TCR signaling	0.989501854289738	-0.0105536399748871	96	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.990903249667095	-0.00913837841201888	99	1	0.00264550264550265	378	8202	5682	PSMA1
R-HSA-72766	Translation	0.992165114285811	-0.00786573969520651	146	2	0.00529100529100529	378	8202	6748,8891	SSR4,EIF2B3
R-HSA-5173105	O-linked glycosylation	0.992485827999703	-0.00754254561623746	103	1	0.00264550264550265	378	8202	55568	GALNT10
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.993793682498003	-0.00622565674899093	107	1	0.00264550264550265	378	8202	6748	SSR4
R-HSA-162582	Signal Transduction	0.993811886050874	-0.00620733968130035	2357	88	0.232804232804233	378	8202	23092,200734,26052,154810,3798,5786,4923,4647,54894,100288637,5578,23279,57406,5881,329,55824,5139,182,6464,93663,8651,51377,8379,7414,11343,2787,843,5567,5796,283869,51466,4893,79971,1742,535,6659,2260,2770,3363,4088,54331,58480,6498,817,8829,5947,27327,4208,2308,2335,10435,7204,4092,5142,57142,7048,10788,10019,5583,10846,51384,79659,114793,6709,2254,5829,8831,2247,7976,157506,5682,23286,84033,23365,3570,5138,5140,23236,6934,22943,401541,3667,57761,56937,57539,101928168,6907,23081	ARHGAP26,SPRED2,DNM3,AMOTL1,KIF5A,PTPRA,NTSR1,MYO7A,RNF43,LOC100288637,PRKCA,NUP160,ABHD6,RAC3,BIRC2,PAG1,PDE3A,JAG1,SHC1,ARHGAP18,SOCS1,UCHL5,MAD1L1,VCL,MGLL,GNG5,CASP10,PRKACB,PTPRK,NPW,EVL,NRAS,WLS,DLG4,ATP6V0A1,SOX4,FGFR1,GNAI1,HTR7,SMAD3,GNG2,RHOU,SKIL,CAMK2D,NRP1,RBP1,TNRC6A,MEF2C,FOXO1,FN1,CDC42EP2,TRIO,SMAD7,PDE4B,RTN4,TGFBR2,IQGAP2,SH2B3,PRKCH,PDE10A,WNT16,DYNC2H1,FMNL2,SPTAN1,FGF9,PXN,SYNGAP1,FGF2,FZD3,RDH10,PSMA1,WWC1,OBSCN,ARHGEF12,IL6R,PDE2A,PDE3B,PLCB1,TCF7L2,DKK1,CENPP,IRS1,TRIB3,PMEPA1,WDR35,LOC101928168,TBL1X,KDM4C
R-HSA-72737	Cap-dependent Translation Initiation	0.995113859676934	-0.0048981165342532	112	1	0.00264550264550265	378	8202	8891	EIF2B3
R-HSA-72613	Eukaryotic Translation Initiation	0.995113859676934	-0.0048981165342532	112	1	0.00264550264550265	378	8202	8891	EIF2B3
R-HSA-418594	G alpha (i) signalling events	0.995720606429913	-0.00428857638202614	236	4	0.0105820105820106	378	8202	54331,283869,2787,2770	GNG2,NPW,GNG5,GNAI1
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.997617862607037	-0.00238497919618372	127	1	0.00264550264550265	378	8202	23279	NUP160
R-HSA-375276	Peptide ligand-binding receptors	0.998951177478225	-0.00104937292099735	193	2	0.00529100529100529	378	8202	283869,4923	NPW,NTSR1
R-HSA-372790	Signaling by GPCR	0.999116175253399	-0.000884215549977216	1230	37	0.0978835978835979	378	8202	200734,2335,5786,4923,7204,5142,5578,57406,5139,5583,6464,10846,51384,7414,11343,2787,5567,6709,283869,2254,4893,8831,2247,7976,5682,1742,84033,23365,5138,5140,23236,2260,2770,3363,3667,54331,817	SPRED2,FN1,PTPRA,NTSR1,TRIO,PDE4B,PRKCA,ABHD6,PDE3A,PRKCH,SHC1,PDE10A,WNT16,VCL,MGLL,GNG5,PRKACB,SPTAN1,NPW,FGF9,NRAS,SYNGAP1,FGF2,FZD3,PSMA1,DLG4,OBSCN,ARHGEF12,PDE2A,PDE3B,PLCB1,FGFR1,GNAI1,HTR7,IRS1,GNG2,CAMK2D
R-HSA-500792	GPCR ligand binding	0.999895437516643	-0.000104567950394457	444	7	0.0185185185185185	378	8202	3363,54331,283869,51384,2787,7976,4923	HTR7,GNG2,NPW,WNT16,GNG5,FZD3,NTSR1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999967554612988	-3.24459133750265e-05	318	3	0.00793650793650794	378	8202	3363,283869,4923	HTR7,NPW,NTSR1
R-HSA-388396	GPCR downstream signaling	0.999988807127821	-1.11929348198817e-05	928	20	0.0529100529100529	378	8202	283869,4923,7204,5142,84033,23365,5138,5578,23236,5140,57406,5139,2770,3363,54331,5583,6464,10846,11343,2787	NPW,NTSR1,TRIO,PDE4B,OBSCN,ARHGEF12,PDE2A,PRKCA,PLCB1,PDE3B,ABHD6,PDE3A,GNAI1,HTR7,GNG2,PRKCH,SHC1,PDE10A,MGLL,GNG5
R-HSA-416700	Other semaphorin interactions	0.999999999974675	-2.53249198941178e-11	19	0	0	378	8202
R-HSA-3000480	Scavenging by Class A Receptors	0.999999999974675	-2.53249198941178e-11	19	0	0	378	8202
R-HSA-190861	Gap junction assembly	0.999999999974675	-2.53249198941178e-11	19	0	0	378	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999974675	-2.53249198941178e-11	19	0	0	378	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999974675	-2.53249198941178e-11	19	0	0	378	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999974675	-2.53249198941178e-11	19	0	0	378	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-916853	Degradation of GABA	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-168268	Virus Assembly and Release	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-1483101	Synthesis of PS	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-192905	vRNP Assembly	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-844623	The IPAF inflammasome	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-380612	Metabolism of serotonin	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-156582	Acetylation	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-888568	GABA synthesis	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-198765	Signalling to ERK5	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-70688	Proline catabolism	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-187042	TRKA activation by NGF	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-75094	Formation of the Editosome	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-1483226	Synthesis of PI	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999975839	-2.41614597253081e-11	2	0	0	378	8202
R-HSA-879518	Transport of organic anions	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-71288	Creatine metabolism	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-376172	DSCAM interactions	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-199983	Golgi to ER Retrograde Transport	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-199997	COPI Mediated Transport	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-3371378	Regulation by c-FLIP	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-5218900	CASP8 activity is inhibited	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-71064	Lysine catabolism	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-1266695	Interleukin-7 signaling	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-211999	CYP2E1 reactions	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-1236977	Endosomal/Vacuolar pathway	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-193048	Androgen biosynthesis	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-71240	Tryptophan catabolism	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-69416	Dimerization of procaspase-8	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-196807	Nicotinate metabolism	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999976296	-2.37040059412158e-11	11	0	0	378	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-209776	Amine-derived hormones	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-912631	Regulation of signaling by CBL	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-5635838	Activation of SMO	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.99999999997738	-2.26204022961258e-11	18	0	0	378	8202
R-HSA-166663	Initial triggering of complement	0.999999999980134	-1.98662191593782e-11	20	0	0	378	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999981749	-1.8251221976594e-11	24	0	0	378	8202
R-HSA-977606	Regulation of Complement cascade	0.999999999981749	-1.8251221976594e-11	24	0	0	378	8202
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.999999999981749	-1.8251221976594e-11	24	0	0	378	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5653890	Lactose synthesis	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-70350	Fructose catabolism	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-77108	Utilization of Ketone Bodies	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-193681	Ceramide signalling	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-198745	Signalling to STAT3	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-1296067	Potassium transport channels	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-351200	Interconversion of polyamines	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999981814	-1.81864960374298e-11	3	0	0	378	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-209968	Thyroxine biosynthesis	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-419771	Opsins	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-418886	Netrin mediated repulsion signals	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-5621480	Dectin-2 family	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-190873	Gap junction degradation	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-2161522	Abacavir transport and metabolism	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999982348	-1.76524872450691e-11	10	0	0	378	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-156587	Amino Acid conjugation	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-391908	Prostanoid ligand receptors	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-196108	Pregnenolone biosynthesis	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-425986	Sodium/Proton exchangers	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-70635	Urea cycle	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-390696	Adrenoceptors	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-3215018	Processing and activation of SUMO	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999984185	-1.5814745114596e-11	9	0	0	378	8202
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.999999999984742	-1.52575437018632e-11	36	0	0	378	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-71262	Carnitine synthesis	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-173736	Alternative complement activation	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-1296061	HCN channels	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-75072	mRNA Editing	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-1296053	Classical Kir channels	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-6783984	Glycine degradation	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-888593	Reuptake of GABA	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-209563	Axonal growth stimulation	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-417973	Adenosine P1 receptors	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-140179	Amine Oxidase reactions	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-428776	Class II GLUTs	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-442745	Activation of CaMK IV	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-390650	Histamine receptors	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-167060	NGF processing	0.999999999984777	-1.52231884739947e-11	4	0	0	378	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999986759	-1.32406814962763e-11	27	0	0	378	8202
R-HSA-192105	Synthesis of bile acids and bile salts	0.999999999986759	-1.32406814962763e-11	27	0	0	378	8202
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.999999999986759	-1.32406814962763e-11	27	0	0	378	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-5652084	Fructose metabolism	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-2161541	Abacavir metabolism	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-3000471	Scavenging by Class B Receptors	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-446205	Synthesis of GDP-mannose	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-167827	The proton buffering model	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-2161517	Abacavir transmembrane transport	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-444209	Free fatty acid receptors	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-70370	Galactose catabolism	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-197264	Nicotinamide salvaging	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-390651	Dopamine receptors	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-71032	Propionyl-CoA catabolism	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-187024	NGF-independant TRKA activation	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-157881	Cyclin B2 mediated events	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-111463	SMAC binds to IAPs	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-561048	Organic anion transport	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-69478	G2/M DNA replication checkpoint	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-391906	Leukotriene receptors	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-68911	G2 Phase	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-112307	Transmission across Electrical Synapses	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-167826	The fatty acid cycling model	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.99999999998694	-1.30603435922653e-11	5	0	0	378	8202
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-428540	Activation of Rac	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-69166	Removal of the Flap Intermediate	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999987049	-1.29508914499893e-11	14	0	0	378	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999987169	-1.28306758748894e-11	22	0	0	378	8202
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999987169	-1.28306758748894e-11	22	0	0	378	8202
R-HSA-166208	mTORC1-mediated signalling	0.999999999987169	-1.28306758748894e-11	22	0	0	378	8202
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.999999999987169	-1.28306758748894e-11	22	0	0	378	8202
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999987169	-1.28306758748894e-11	22	0	0	378	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999987169	-1.28306758748894e-11	22	0	0	378	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-193639	p75NTR signals via NF-kB	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-156711	Polo-like kinase mediated events	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-1834941	STING mediated induction of host immune responses	0.999999999988762	-1.12384563474434e-11	16	0	0	378	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-164944	Nef and signal transduction	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-1253288	Downregulation of ERBB4 signaling	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-428643	Organic anion transporters	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-73928	Depyrimidination	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-804914	Transport of fatty acids	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-196783	Coenzyme A biosynthesis	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-444821	Relaxin receptors	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-194313	VEGF ligand-receptor interactions	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-5632681	Ligand-receptor interactions	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-192456	Digestion of dietary lipid	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-1483148	Synthesis of PG	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.99999999998924	-1.07597725268467e-11	8	0	0	378	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-68952	DNA replication initiation	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-70921	Histidine catabolism	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-388479	Vasopressin-like receptors	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-500753	Pyrimidine biosynthesis	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-171052	LDL-mediated lipid transport	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-176417	Phosphorylation of Emi1	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-1237112	Methionine salvage pathway	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-171319	Telomere Extension By Telomerase	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-174362	Transport and synthesis of PAPS	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-77111	Synthesis of Ketone Bodies	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-205025	NADE modulates death signalling	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-111957	Cam-PDE 1 activation	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-187015	Activation of TRKA receptors	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-3065679	SUMO is proteolytically processed	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-428808	Na+-dependent glucose transporters	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-444257	RSK activation	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-166662	Lectin pathway of complement activation	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.99999999998951	-1.04904906650854e-11	6	0	0	378	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-389542	NADPH regeneration	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-163316	Mitochondrial transcription termination	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-3248023	Regulation by TREX1	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-169131	Inhibition of PKR	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1483076	Synthesis of CL	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-140180	COX reactions	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-162585	Uncoating of the HIV Virion	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-164525	Plus-strand DNA synthesis	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-164516	Minus-strand DNA synthesis	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-1300645	Acrosome Reaction	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5619084	ABC transporter disorders	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.99999999998968	-1.0319509136103e-11	1	0	0	378	8202
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.999999999990695	-9.30456597329237e-12	31	0	0	378	8202
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999992388	-7.61153345851495e-12	23	0	0	378	8202
R-HSA-389948	PD-1 signaling	0.999999999992388	-7.61153345851495e-12	23	0	0	378	8202
R-HSA-5627123	RHO GTPases activate PAKs	0.999999999992388	-7.61153345851495e-12	23	0	0	378	8202
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.999999999992388	-7.61153345851495e-12	23	0	0	378	8202
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999992388	-7.61153345851495e-12	23	0	0	378	8202
R-HSA-211976	Endogenous sterols	0.999999999992388	-7.61153345851495e-12	23	0	0	378	8202
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.999999999992388	-7.61153345851495e-12	23	0	0	378	8202
R-HSA-3322077	Glycogen synthesis	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-211935	Fatty acids	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-391903	Eicosanoid ligand-binding receptors	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-901042	Calnexin/calreticulin cycle	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-194223	HDL-mediated lipid transport	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-975577	N-Glycan antennae elongation	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-5358508	Mismatch Repair	0.999999999994117	-5.88284234772465e-12	15	0	0	378	8202
R-HSA-113510	E2F mediated regulation of DNA replication	0.999999999994192	-5.80832565216974e-12	33	0	0	378	8202
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.999999999994192	-5.80832565216974e-12	33	0	0	378	8202
R-HSA-72187	mRNA 3'-end processing	0.999999999994192	-5.80832565216974e-12	33	0	0	378	8202
R-HSA-157858	Gap junction trafficking and regulation	0.999999999994528	-5.47206037615923e-12	30	0	0	378	8202
R-HSA-174824	Lipoprotein metabolism	0.999999999994528	-5.47206037615923e-12	30	0	0	378	8202
R-HSA-420029	Tight junction interactions	0.999999999994528	-5.47206037615923e-12	30	0	0	378	8202
R-HSA-446652	Interleukin-1 signaling	0.999999999994883	-5.11666616344867e-12	44	0	0	378	8202
R-HSA-73856	RNA Polymerase II Transcription Termination	0.999999999995674	-4.32640871252211e-12	42	0	0	378	8202
R-HSA-1461957	Beta defensins	0.999999999995674	-4.32640871252211e-12	42	0	0	378	8202
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.999999999995674	-4.32640871252211e-12	42	0	0	378	8202
R-HSA-1251985	Nuclear signaling by ERBB4	0.999999999995738	-4.2616338144587e-12	40	0	0	378	8202
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.999999999995738	-4.2616338144587e-12	40	0	0	378	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-209560	NF-kB is activated and signals survival	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-2029481	FCGR activation	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-350054	Notch-HLH transcription pathway	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-977441	GABA A receptor activation	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-209822	Glycoprotein hormones	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.999999999995853	-4.14659661483643e-12	13	0	0	378	8202
R-HSA-2022854	Keratan sulfate biosynthesis	0.999999999997021	-2.97944736380109e-12	28	0	0	378	8202
R-HSA-190828	Gap junction trafficking	0.999999999997021	-2.97944736380109e-12	28	0	0	378	8202
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.999999999997021	-2.97944736380109e-12	28	0	0	378	8202
R-HSA-72764	Eukaryotic Translation Termination	0.999999999997558	-2.44196923239962e-12	85	0	0	378	8202
R-HSA-1474165	Reproduction	0.999999999998214	-1.78564201841949e-12	26	0	0	378	8202
R-HSA-975298	Ligand-gated ion channel transport	0.999999999998214	-1.78564201841949e-12	26	0	0	378	8202
R-HSA-2029485	Role of phospholipids in phagocytosis	0.999999999998214	-1.78564201841949e-12	26	0	0	378	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.999999999998214	-1.78564201841949e-12	26	0	0	378	8202
R-HSA-1187000	Fertilization	0.999999999998214	-1.78564201841949e-12	26	0	0	378	8202
R-HSA-5334118	DNA methylation	0.999999999998266	-1.73419752717187e-12	62	0	0	378	8202
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.999999999999633	-3.66797536765091e-13	48	0	0	378	8202
R-HSA-5668914	Diseases of metabolism	1.00000000000023	2.29512716977636e-13	45	0	0	378	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-156581	Methylation	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-203615	eNOS activation	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-3371511	HSF1 activation	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-2022857	Keratan sulfate degradation	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-3656237	Defective EXT2 causes exostoses 2	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-210990	PECAM1 interactions	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-71384	Ethanol oxidation	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-211958	Miscellaneous substrates	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-417957	P2Y receptors	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-202670	ERKs are inactivated	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-844456	The NLRP3 inflammasome	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000000078	7.81656453944485e-13	12	0	0	378	8202
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	1.00000000000095	9.52582877039141e-13	86	0	0	378	8202
R-HSA-381753	Olfactory Signaling Pathway	1.00000000000101	1.01321540535411e-12	381	0	0	378	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-174577	Activation of C3 and C5	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-447043	Neurofascin interactions	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-199920	CREB phosphorylation	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-429593	Inositol transporters	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-74182	Ketone body metabolism	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-448706	Interleukin-1 processing	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-427601	Multifunctional anion exchangers	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-2214320	Anchoring fibril formation	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000000118	1.17845509774621e-12	7	0	0	378	8202
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-622312	Inflammasomes	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-140534	Ligand-dependent caspase activation	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-5627117	RHO GTPases Activate ROCKs	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-69205	G1/S-Specific Transcription	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-174800	Chylomicron-mediated lipid transport	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-70221	Glycogen breakdown (glycogenolysis)	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000000155	1.54843934318053e-12	17	0	0	378	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-977068	Termination of O-glycan biosynthesis	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-1538133	G0 and Early G1	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-3295583	TRP channels	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-2262749	Cellular response to hypoxia	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	1.00000000000226	2.26107478708212e-12	25	0	0	378	8202
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000000477	4.77481936963743e-12	29	0	0	378	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000000477	4.77481936963743e-12	29	0	0	378	8202
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	1.00000000000542	5.42378614071972e-12	64	0	0	378	8202
R-HSA-927802	Nonsense-Mediated Decay (NMD)	1.00000000000652	6.52291999809055e-12	106	0	0	378	8202
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	1.00000000000652	6.52291999809055e-12	106	0	0	378	8202
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000000665	6.64775541607438e-12	70	0	0	378	8202
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	1.00000000000675	6.74610319277533e-12	61	0	0	378	8202
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000000677	6.76764835598265e-12	65	0	0	378	8202
R-HSA-3928663	EPHA-mediated growth cone collapse	1.00000000000704	7.03842213221647e-12	34	0	0	378	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000000732	7.31537710664163e-12	60	0	0	378	8202
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000000732	7.32242680528013e-12	55	0	0	378	8202
R-HSA-72649	Translation initiation complex formation	1.00000000000732	7.32242680528013e-12	55	0	0	378	8202
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1.00000000000796	7.95753523979431e-12	38	0	0	378	8202
R-HSA-166658	Complement cascade	1.00000000000796	7.95753523979431e-12	38	0	0	378	8202
R-HSA-192823	Viral mRNA Translation	1.0000000000083	8.29673342755163e-12	84	0	0	378	8202
R-HSA-156902	Peptide chain elongation	1.0000000000083	8.29673342755163e-12	84	0	0	378	8202
R-HSA-156842	Eukaryotic Translation Elongation	1.00000000000863	8.62679418936406e-12	88	0	0	378	8202
R-HSA-380108	Chemokine receptors bind chemokines	1.00000000000958	9.58294904404254e-12	56	0	0	378	8202
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1.00000000000958	9.58294904404254e-12	56	0	0	378	8202
R-HSA-211981	Xenobiotics	1.00000000001032	1.03182472197939e-11	21	0	0	378	8202
R-HSA-2024096	HS-GAG degradation	1.00000000001032	1.03182472197939e-11	21	0	0	378	8202
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1.00000000001032	1.03182472197939e-11	21	0	0	378	8202
R-HSA-156588	Glucuronidation	1.00000000001032	1.03182472197939e-11	21	0	0	378	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000001076	1.07590338545444e-11	39	0	0	378	8202
R-HSA-6783310	Fanconi Anemia Pathway	1.00000000001076	1.07590338545444e-11	39	0	0	378	8202
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	1.00000000001076	1.07590338545444e-11	39	0	0	378	8202
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	1.00000000001076	1.07590338545444e-11	39	0	0	378	8202
R-HSA-165159	mTOR signalling	1.00000000001076	1.07590338545444e-11	39	0	0	378	8202
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	1.00000000001076	1.07590338545444e-11	39	0	0	378	8202
R-HSA-2299718	Condensation of Prophase Chromosomes	1.00000000001104	1.1038645806141e-11	71	0	0	378	8202
R-HSA-72689	Formation of a pool of free 40S subunits	1.00000000001229	1.22859237607287e-11	94	0	0	378	8202
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	1.00000000001492	1.49174162053219e-11	104	0	0	378	8202
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.00000000001681	1.68131011134194e-11	89	0	0	378	8202
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000001899	1.89919843643339e-11	50	0	0	378	8202
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	1.00000000002563	2.56323298692556e-11	105	0	0	378	8202
